Impact of the COVID-19 pandemic on cancer care

© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
EDITORIAL
Impact of the COVID-19 pandemic on cancer care
Junjie Huang, PhD, MSc1,2,3; Harry HX Wang, PhD1; ZJ Zheng, MD, PhD4,5; Martin CS Wong, MD, MPH2,3,5,6
1 Editor, Hong Kong Medical Journal
2 The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
3 Centre for Health Education and Health Promotion, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
4 International Editorial Advisory Board, Hong Kong Medical Journal
5 Department of Global Health, School of Public Health, Peking University, Beijing, China
6 Editor-in-Chief, Hong Kong Medical Journal
 
Corresponding author: Prof Martin CS Wong (wong_martin@cuhk.edu.hk)
 
 Full paper in PDF
 
Status of COVID-19 worldwide and in Hong Kong
As of November 2022, there have been >600 million confirmed cases of coronavirus disease 2019 (COVID-19) worldwide, including 6 million deaths, since the pandemic began in 2020.1 In Hong Kong, the number of cases has reached >2 million, with >10 000 deaths. Since the initiation of the vaccination programme in 2021, >94% and >83% of the population have received the first and third doses, respectively.2 In addition to its impacts on infected individuals, the COVID-19 pandemic has affected the general public and physicians.3 4 5
 
Relationship between the COVID-19 pandemic and cancer
Patients with cancer are more aware of the impact of COVID-19 because of their increased risk of infection. This risk of infection arises from factors such as the presence of an immunocompromised status related to disease or treatment, the nature of cancer as a major co-morbidity that enhances the risks of COVID-19–related morbidity and mortality, and the need for frequent visits to medical centres to receive anticancer treatment and cancer-related care.6 7 A study conducted in China showed that patients with both COVID-19 and cancer had 3.5-fold greater odds of requiring mechanical ventilation, intensive care unit admission, or death, compared with healthy individuals.8 Patients with cancer also had a higher risk of COVID-19 infection and experienced worse outcomes, compared with patients who did not have cancer.9 10 Additionally, one study showed that the onset of COVID-19 could lead to higher mortality (24%) among patients with cancer than among patients without cancer (3%).10 11
 
Impact of COVID-19 on cancer screening
The COVID-19 pandemic has led to reductions in cancer screening services in relation to the suspension of non-urgent medical services, rescheduling to focus on COVID-19–related services, and reduced patient motivation to seek care.12 13 14 Affected services include colorectal, cervical, lung, and prostate cancer screenings.
 
For example, colorectal cancer screening capacity in the United States has decreased by 86%, and up to 1500 colorectal cancer cases have been missed or delayed in Australia during the COVID-19 pandemic thus far.12 The effectiveness of colorectal cancer screening services is compromised because there is an increased risk of COVID-19 transmission associated with endoscopy and the exposure of vulnerable people to the hospital environment. These impacts have been reported in multiple countries worldwide, including the United States, United Kingdom, Ireland, Australia, and Italy.12 Additionally, one study showed that a large proportion of women in Hong Kong have never undergone cervical cancer screening; this lack of screening has been exacerbated during the COVID-19 pandemic because of restricted access to medical centres.13 Social distancing and concerns about potential exposure have deterred women from seeking clinical care, thereby reducing in-person screening.10 Another study revealed the potential for missed cancer diagnoses (prostate, 19.7%; colorectal, 10%; and lung, 3%) because of the COVID-19 pandemic in Hong Kong.14
 
Impact of COVID-19 on cancer treatment and patient life
The COVID-19 pandemic has had diverse effects on patients with cancer; the greatest impacts have involved effects on patients’ lives and access to cancer treatment modalities. Researchers in Hong Kong recently published the results of a multidisciplinary cross-sectional survey that examined the real-world impact of the pandemic on patients with cancer in May 2020.15 The survey found that patients accepted increased physical distance from medical staff during consultations; patients were able to refill their medications without oncologist consultations. Although some patients receiving chemotherapy or radiotherapy chose not to modify their treatment plans, many patients were willing to balance a change in treatment efficacy or side-effect profile with the ability to undergo out-patient treatment. Among patients with cancer, social distancing measures during the pandemic have changed attitudes and experiences related to medical consultation and cancer treatment; these changes have tended to continue as the pandemic severity has declined.15 16 17
 
Implications for cancer care during the pandemic
Research has shown that although cancer services continue to function with adaptive measures and patient acceptance, many patients are hesitant to visit hospitals. This hesitance is related to inadequate information regarding COVID-19 among patients with cancer, particularly with respect to hospital safety measures focused on COVID-19.16 Therefore, patients with cancer should receive timely information about COVID-19 from official sources, through various channels (eg, the internet and social media), regardless of their age and socio-economic status.
 
Research findings have also emphasised the real-world needs of patients with cancer in terms of individualised dietetic and occupational health assessments, early in-patient or out-patient interventions, and self-help materials for cancer care developed in the context of the pandemic. Such considerations should include telemedicine, which has become popular during the pandemic; because it sometimes cannot be accessed and understood by underprivileged individuals (eg, older adults and less educated patients), telemedicine should not fully replace conventional physiotherapy and rehabilitation.17 The issue of telemedicine was also addressed in a study focused on new cancer diagnoses. Among patients who experienced difficulty understanding their cancer diagnosis (eg, cancer type, stage, and treatment options), the use of telemedicine may lead to increased anxiety and confusion. Thus, clinical visits are preferable for new patients.18
 
The decision to continue or discontinue treatment (chemotherapy or surgery) is a key consideration for patients with cancer who may have an increased risk of infection during the pandemic. The results of some studies suggest that adjuvant chemotherapy or surgery can be postponed for patients with cancer who exhibit stable disease, whereas the results of other studies suggest that those aspects of treatment should be continued to prevent COVID-19 transmission. The findings of one study indicated that adjuvant chemotherapy with curative intent should be maintained for early-stage cancer.18 Robust precautionary measures should be implemented for chemotherapy infusion areas (eg, nucleic acid testing, quarantine, and isolation) to protect immunocompromised patients.18 Nevertheless, that study did not include patients with cancer who received treatments in private clinics. Moreover, future studies should cover longer periods of time (ie, not limited to the first wave of the COVID-19 pandemic), considering that there were five waves of COVID-19 in Hong Kong before November 2022.19 In addition to clinical outcomes, patient-reported outcomes should be explored among patients with cancer.20 Additional studies are needed regarding the long-term impact of the COVID-19 pandemic on cancer care to determine how it may affect the cancer burden in Hong Kong during the post-pandemic era.
 
Author contributions
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Acknowledgement
We thank Ms Yuet-yan Wong, Senior Research Assistant from the Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, for her assistance in the literature search and review.
 
References
1. World Health Organization (WHO). WHO coronavirus (COVID-19) dashboard. Updated 2022 Nov 27. Available from: https://covid19.who.int/. Accessed 30 Nov 2022.
2. Hong Kong SAR Government. Coronavirus disease (COVID-19) in HK. Updated 2022 Nov 27. Available from: https://chp-dashboard.geodata.gov.hk/covid-19/en.html. Accessed 30 Nov 2022.
3. Wang Y, Luo S, Zhou CS, et al. Clinical and radiological characteristics of COVID-19: a multicentre, retrospective, observational study. Hong Kong Med J 2021;27:7-17. Crossref
4. Tam VC, Tam SY, Khaw ML, Law HK, Chan CP, Lee SW. Behavioural insights and attitudes on community masking during the initial spread of COVID-19 in Hong Kong. Hong Kong Med J 2021;27:106-12. Crossref
5. Yu EY, Leung WL, Wong SY, Liu KS, Wan EY; HKCFP Executive and Research Committee. How are family doctors serving the Hong Kong community during the COVID-19 outbreak? A survey of HKCFP members. Hong Kong Med J 2020;26:176-83. Crossref
6. Kong X, Qi Y, Huang J, et al. Epidemiological and clinical characteristics of cancer patients with COVID-19: a systematic review and meta-analysis of global data. Cancer Lett 2021;508:30-46. Crossref
7. Al-Quteimat OM, Amer AM. The impact of the COVID-19 pandemic on cancer patients. Am J Clin Oncol 2020;43:452-5. Crossref
8. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335-7. Crossref
9. Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020;21:e180. Crossref
10. Yeoh CB, Lee KJ, Rieth EF, et al. COVID-19 in the cancer patient. Anesth Analg 2020;131:16-23.Crossref
11. Kim YJ, Lee ES, Lee YS. High mortality from viral pneumonia in patients with cancer. Infect Dis (Lond) 2019;51:502-9. Crossref
12. Huang JJ, Zhang L, Xu WH, Wong MC. Impact of COVID-19 on colorectal cancer screening: evidence and recommendations. J Soc Physicians Hong Kong 2021;13:4-6.
13. Ngu SF, Lau LS, Li J, et al. Human papillomavirus self-sampling for primary cervical cancer screening in under-screened women in Hong Kong during the COVID-19 pandemic. Int J Environ Res Public Health 2022;19:2610. Crossref
14. Vardhanabhuti V, Ng KS. Differential impact of COVID-19 on cancer diagnostic services based on body regions: a public facility-based study in Hong Kong. Int J Radiat Oncol Biol Phys 2021;111:331-6. Crossref
15. Bao KK, Cheung KM, Chow JC, et al. 1709P Cancer patients’ perspectives on the real-world impact of COVID-19 pandemic: a multidisciplinary survey. Ann Oncol 2020;31:S1006. Crossref
16. Chan WL, Ho PP, Yuen K. Social distancing and cancer care during the COVID-19 pandemic. BMJ Support Palliat Care 2020 Sep 4. Epub ahead of print. Crossref
17. Lou E, Teoh D, Brown K, et al. Perspectives of cancer patients and their health during the COVID-19 pandemic. PLoS One 2020;15:e0241741. Crossref
18. Jindal V, Sahu KK, Gaikazian S, Siddiqui AD, Jaiyesimi I. Cancer treatment during COVID-19 pandemic. Med Oncol 2020;37:58. Crossref
19. Hong Kong SAR Government. Archive of statistics on 5th wave of COVID-19. Updated 2022 Nov 27. Available from: https://www.coronavirus.gov.hk/eng/5th-wave-statistics. html. Accessed 30 Nov 2022.
20. Ng CF, Kong KY, Li CY, et al. Patient-reported outcomes after surgery or radiotherapy for localised prostate cancer: a retrospective study. Hong Kong Med J 2020;26:95-101. Crossref

Ageing and frailty

© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
EDITORIAL
Ageing and frailty
Ben YF Fong, MPH (Syd), FHKAM (Community Medicine)
Division of Science, Engineering and Health Studies, College of Professional and Continuing Education, The Hong Kong Polytechnic University, Hong Kong
 
Corresponding author: Dr Ben YF Fong (ben.fong@cpce-polyu.edu.hk)
 
 Full paper in PDF
 
Ageing and healthcare services
The consequences of population ageing are major concerns for most governments, particularly in economically developed countries and regions. This has been exacerbated by the ongoing coronavirus disease 2019 (COVID-19) pandemic. In Hong Kong, government officials, professionals, academics, community leaders, parents, family members, carers, teachers and frontline workers have been facing unpredictable and changeable situations arising from measures introduced to limit the number of COVID-19 cases and associated deaths. There has also been excess mortality among the older population, mostly residents of elderly homes, during the fifth wave of the outbreak in early 2022.1 In this issue of Hong Kong Medical Journal, Luk and Chan2 highlight that the measures intended to protect the elderly population may have had the unintended adverse effect of worsening frailty and sarcopenia. Policymakers and healthcare providers are often caught off guard no matter how much time, effort, and resources have been invested in planning and preparing for public health crises.
 
Ageing populations aggravate the demand on social and health services, and Hong Kong’s population—with one of the world’s longest life expectancies of 85.2 years—is no exception. Longevity naturally results in more age-related problems such as declining functional and intrinsic capacities, including frailty, that require care and attention by family members, carers, and healthcare providers.3 The Hong Kong population aged ≥65 years is predicted to increase from 16% in 2017 to 34% in 2066.4 Many older adults need regular and long-term care; most of them have at least one common chronic condition resulting from ageing. Older adults also consume 6 times more in-patient services than do younger patients, and this represents a continuing burden to the healthcare system, affecting its sustainability.5 6 The traditional model of public financing and delivery of acute-centric hospital-oriented care leads to significant and negative effects on accessibility, equity, and sustainability. In contrast, primary care effectively and efficiently provides better and more appropriate care to the residents in the best interests of the community.7
 
Geriatric syndromes
Complex health states commonly called geriatric syndromes are unavoidable in ageing and caused by a number of potentially concurrent bodily conditions like frailty, urinary incontinence, recurrent falls, mental impairment and pressure ulcers. Frailty is an emerging global health burden coming from the ageing populations. It is a syndrome arising from continuing changes and decline across multiple physiological systems of the immune, musculoskeletal and endocrine systems, often considered as minor and associated with fatigue, decreased muscle strength, and increase in dependence, falls, hospitalisation, mortality, and vulnerability to stressors as well as health costs. The affected older adults look shrinking, feel weak and exhausted, move slowly, resulting in low level of activity, cognitive impairment, slow gait, and poor balance. Thus, frailty is an important predictor and health indicator for the older adults. The prevalence increases with age and is found to be lower in the rural ageing population. Risk factors include multi-morbidity, polypharmacy, female gender, low socio-economic status and educational background, poor diet, and physical inactivity.8 9 About 10% of older adults are affected by frailty but they may maintain almost full daily life capacity. However, there is potential of severe long-term effects on the wellbeing of individuals.10 The affected older adults are less ready or able to recover from illnesses or injuries. This can have an obvious impact on the quality of daily living and life expectancy.11
 
Frailty and sarcopenia
As noted by Luk and Chan,2 frailty and sarcopenia are closely related syndromes in geriatrics. Ageing entails the catabolism of muscles resulting in sarcopenia and frailty, and these often overlap in clinical presentation. The loss of muscle mass and function in sarcopenia is usually related to ageing but can also be induced by starvation, malnutrition, or inactivity. In contrast, frailty is age-related multi-system impairment and loss of weight and energy, but is not limited specifically to the muscles. Gait speed and hand grip strength are employed as diagnostic measures for both frailty and sarcopenia. Treatments for both of these two conditions also overlap, including adequate protein and vitamin D supplementation, plus resistance exercise programmes, which may not be feasible for the old and frail.12 13
 
Detection and management of frailty
Lifestyle risk factors are potentially modifiable by specific interventions and preventive actions. The concept of frailty is increasingly being discussed in public health, and primary, acute and specialist care.9 However, frailty may be missed or ignored as a process of normal ageing.14 It is thus imperative to identify frailty routinely, as part of the comprehensive geriatric assessments in older adults, using validated simple-to-use screening tools.
 
In this issue of Hong Kong Medical Journal, Umehara et al15 developed prediction models for the prognosis of pre-frailty and frailty in older patients with heart failure, and evaluated their accuracy. They found that the patient’s condition at admission was predictive of pre-frailty and frailty, and that cardiac rehabilitation may help to improve frailty after cardiac intervention. These findings are consistent with a recent review by Ijaz et al,16 who found that tailored cardiac rehabilitation in patients with cardiac failure was associated with positive results on frailty. Those authors therefore proposed that active screening should be incorporated into a patient-centred model of cardiovascular practice in order to identify frail older adults who would benefit from frailty intervention, particularly after cardiovascular interventions.16 Such practices should be adopted in Hong Kong where cardiovascular diseases are prevalent and detection of early or pre-frailty will be beneficial to the older adults at higher risk.
 
Management of co-morbid conditions is essential when caring for frailty. Walking and simple body movements are considered useful in improving strength, thereby alleviating weakness, even for the very old.17 The author started learning sitting tai chi a year before and had found it very effective for relaxation, co-ordination and positive feeling. Treatment plans must be individualised to address the age, goals of care and expectations of the patient and their family. When indicated, palliative care and symptom control can be considered for frailer older people.14
 
Ageing with frailty and dignity
Frailty is drawing more attention worldwide because of the increasing ageing populations. It is being better defined through consensus conferences, and research in ageing and the associated intrinsic capacity. Frailty is considered as partly preventable and thus early detection with screening tools is a critical step in routine geriatric assessment. Targeted interventions and management plans can then be initiated to allow the older adults to live a quality life with dignity, as part of the holistic and humanistic approaches in elderly care and services.18 19
 
Author contributions
The author contributed to the concept or design, drafting of the manuscript, and critical revision for important intellectual content. The author had full access to the data, contributed to the study, approved the final version for publication, and takes responsibility for its accuracy and integrity.
 
Conflicts of interest
The author has disclosed no conflicts of interest.
 
References
1. Cheung PH, Chan CP, Jin DY. Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022. Emerg Microbes Infect 2022;11:1072-8.Crossref
2. Luk JK, Chan DK. Frailty and sarcopenia—from theory to practice. Hong Kong Med J 2022;28:392-5.
3. Yu R, Leung J, Lum CM, et al. A comparison of health expectancies over 10 years: implications for elderly service needs in Hong Kong. Int J Public Health 2019;64:731-42. Crossref
4. Census and Statistics Department, Hong Kong SAR Government. Hong Kong Population Projections 2017-2066. Available from: https://www.statistics.gov.hk/pub/B1120015072017XXXXB0100.pdf. Accessed 20 Aug 2022.
5. Elderly Commission, Hong Kong SAR Government. Report on healthy ageing executive summary. Available from: https://www.elderlycommission.gov.hk/en/library/Ex-sum.htm#2. Accessed 20 Aug 2022.
6. Kwok CL, Lee CK, Lo WT, Yip PS. The contribution of ageing to hospitalisation days in Hong Kong: a decomposition analysis. Int J Health Policy Manag 2017;6:155-64. Crossref
7. Ng TK, Fong BY, Kwong CK. Transition of hospital acute-centric to long term care in an ageing population in Hong Kong—is it an issue of service gap? Asia Pac J Health Manag 2019;14:11-5. Crossref
8. Woo J, Zheng Z, Leung J, Chan P. Prevalence of frailty and contributory factors in three Chinese populations with different socioeconomic and healthcare characteristics. BMC Geriatr 2015;15:163. Crossref
9. Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet 2019;394:1365-75. Crossref
10. Age UK. Understanding frailty. Available from: https://www.ageuk.org.uk/our-impact/policy-research/frailty-in-older-people/understanding-frailty/. Accessed 20 Aug 2022.
11. Royal College of Nursing. Frailty in older people. Available from: https://www.rcn.org.uk/clinical-topics/Older-people/Frailty. Accessed 20 Aug 2022.
12. Dodds R, Sayer AA. Sarcopenia and frailty: new challenges for clinical practice. Clin Med (Lond) 2016;16:455-8. Crossref
13. Cederholm T. Overlaps between frailty and sarcopenia definitions. Nestle Nutr Inst Workshop Ser 2015;83:65-9. Crossref
14. Allison R 2nd, Assadzandi S, Adelman M. Frailty: evaluation and management. Am Fam Physician 2021;103:219-26.
15. Umehara T, Katayama N, Kaneguchi A, Iwamoto Y, Tsunematsu M, Kakehashi M. Models to predict prognosis in older patients with heart failure complicated by pre-frailty and frailty: a pilot prospective cohort study. Hong Kong Med J 2022;28:356-66.Crossref
16. Ijaz N, Buta B, Xue Q, et al. Interventions for frailty among older adults with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol 2022;79:482-503. Crossref
17. Johns Hopkins Medicine. Stay strong: four ways to beat the frailty risk. Available from: https://www.hopkinsmedicine.org/health/wellness-and-prevention/stay-strong-four-ways-to-beat-the-frailty-risk. Accessed 20 Aug 2022.
18. Kwak D, Thompson LV. Frailty: past, present, and future? Sports Med Health Sci 2021;3:1-10. Crossref
19. Law VT, Fong BY, editors. Ageing with Dignity in Hong Kong and Asia: Holistic and Humanistic Care. Singapore: Springer; 2022. Crossref

Credentialling—myths, challenges and spirit

Hong Kong Med J 2022 Aug;28(4):280–1  |  Epub 15 Jul 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
EDITORIAL
Credentialling—myths, challenges and spirit
Gilberto KK Leung, FHKAM (Surgery)1; LLM, Paul BS Lai, FHKAM (Surgery), LLM2
1 President, Hong Kong Academy of Medicine
2 Vice-President (Education & Examinations), Hong Kong Academy of Medicine
 
Corresponding author: Prof Gilberto KK Leung (gilberto@hku.hk)
 
 Full paper in PDF
 
 
In early 2022, the Hong Kong Academy of Medicine (the Academy) promulgated a credentialling mechanism for endovascular neurointervantional procedures.1 The aim of credentialling is to provide formal accreditation of attainment of clinical competencies as a means to protect patients and maintain trust.2 Taking into account the transdisciplinary nature of neuroendovascular treatment, the exercise is a joint effort by three Academy Colleges—the Hong Kong College of Physicians, the Hong Kong College of Radiologists, and The College of Surgeons of Hong Kong—and represents a key development in our collective effort to uphold professional standards.
 
The issue of credentialling was raised at the Academy in 2014 by Past President Prof CS Lau, who was Vice President (Education & Examinations) at that time. It was agreed that credentialling should focus on high-risk and complex procedures involving special skills and technologies that fall outside the curricula of specialist training. Neuroendovascular intervention meets these criteria, given the ongoing advancement in endovascular technologies, its potential impact on patient well-being, and the fact that specialist training focuses mainly on theoretical knowledge but not technical proficiency in this area. Post-fellowship credentialling thus serves to assure that an individual doctor is fit for providing such treatment through attaining and maintaining the requisite practical expertise and clinical experience.
 
Under the established mechanism, Fellows with recognised competencies in neuroendovascular intervention were vetted, and those meeting the required standard were exempted from the initial credentialling process in June 2022. After this so-called ‘grandfathering’ process, credentialled doctors would then be subject to 3-year cycles of continuous credentialling, alongside those who fulfil the requirement of initial credentialling in future. Failure to maintain continuous credentialling will lead to the removal of the credential, although the doctor concerned may apply for revalidation. The spirit of credentialling therefore moves away from the assumptions that all specialists in Neurology, Neurosurgery, or Radiology are competent at performing neuroendovascular interventions, or that previous attainment of competency automatically implies perpetual fitness-to-practice. It is a necessary and well-established approach to addressing an area of practice characterised by rapid development and a close correlation between practical experience and performance.
 
Credentialling is indicative rather than restrictive, in that it only indicates who possesses the required level of competency without restricting those who are not credentialled from practising in the designated area. Credentialing by and of itself does not guarantee or imply that the treatment given by the doctor in a particular instance is compliant with professional standards. The label carries no legal or regulatory mandate, and it is up to service providers, regulatory bodies, or the courts to make reference to an individual doctor’s credentialling status, or the lack thereof, in granting privileges, licencing, or assessing standards of care. As the list of credentialled doctors is publicly accessible, it will empower patients, ever vulnerable to information asymmetry within the complex world of medical subspecialisation, to make the right decision.3 Ultimately, the responsibility is on the doctor, and on those contracting or engaging the doctor’s services, to ensure that they are indeed fit for providing the treatment.
 
Credentialling is supposed to add value to patient care and not to be undertaken for its own sake. A major challenge in devising the above mechanism concerns setting the appropriate case volume required for a doctor to obtain and maintain the credential. The disparate arrangement of endovascular services in Hong Kong is such that each centre cares for only a small number of patients, which limits the number of doctors eligible for credentialling. However, each centre will need an adequate number of credentialled specialists for optimal service provision. So, although a higher case volume requirement is better for quality, a balance must be struck against quantity. There might also be the tendency for some doctors, acting in good faith or otherwise, to stretch indications for intervention beyond what would be in patients’ best interests so as to attain the required case volume. These two issues are necessarily evolving and will require regular review. Cross-college recognition of training and collaborations in rotational attachment, crucial for sustainability and quality assurrance, are currently under consideration.
 
Looking forward, there are other areas of practice that will conceivably benefit from credentialling, especially those that fall outside of or across recognised medical or dental specialties where oversight and regulation are weak or non-existent, and where patients are particularly vulnerable due to lack of information. To reach into these areas will entail a rethink of our framework of postgraduate training as well as extensive consultation with and considerable support from various stakeholders. It will not be a light challenge but is certainly one worth taking by the Academy and our Fellows for patients’ benefits.
 
Author contributions
Both authors contributed to the editorial, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
Both authors have declared no conflict of interest.
 
References
1. Hong Kong Academy of Medicine. Credentialling for endovascular interventional procedures. Available from: https://www.hkam.org.hk/en/news/credentialling-endovascular- neurointerventional-procedures. Accessed 24 Jun 2022.
2. General Medical Council. Report of the GMC Credentialing Working Group. Available from: https://www.gmc-uk.org/-/media/documents/03___Annex_A___Final_Report_of_the_Credentialing_Working_Group.pdf_61528614.pdf. Accessed 24 Jun 2022.
3. Hong Kong Academy of Medicine. List of specialists exempted from initial credentialling for endovascular neurointerventional procedures. Available from: https://www.hkam.org.hk/en/news/2022-07-04-Specialists-Exempted. Accessed 7 Jul 2022.

Strengthening attributes of primary care to improve patients’ experiences and population health: from rural village clinics to urban health centres

© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
EDITORIAL
Strengthening attributes of primary care to improve patients’ experiences and population health: from rural village clinics to urban health centres
Harry HX Wang, PhD1,2,3 #; Yu Ting Li, MPH4 #; Martin CS Wong, MD, MPH5,6
1 School of Public Health, Sun Yat-Sen University, Guangzhou, China
2 Department of General Practice, The Second Hospital of Hebei Medical University, Shijiazhuang, China
3 Usher Institute, Deanery of Molecular, Genetic and Population Health Sciences, The University of Edinburgh, Scotland, United Kingdom
4 State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China
5 JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
6 Editor-in-Chief, Hong Kong Medical Journal
# The first two authors contributed equally to this work
 
Corresponding author: Prof Martin CS Wong (wong_martin@cuhk.edu.hk)
 
 Full paper in PDF
 
Primary care is an integrated model of care underpinned by the discipline of general practice (GP), aiming to optimise population health and reduce disparities across the population. The key attributes of primary care—first contact, continuity, coordination, comprehensiveness, and community orientation and family centeredness—enable a high-value service delivery to address the wider determinants of health.1 In recent years, primary care transformation has taken place across the globe. In Scotland, for example, ‘GP clusters’ have been introduced to provide a more holistic, values-based approach to health and social care integration. It aims to provide a mechanism for a focus on quality improvement to encourage primary care to adjust clinical foci to local aims and needs, alongside the expansion of multidisciplinary teams to address workload and population health inequalities.2 In Hong Kong, strategies to foster continuity of care have been developed, such as the Elderly Health Care Voucher Scheme to encourage a regular source of care best suited to people’s needs, the integration of the medical workforce in Community Health Centres, which is particularly important for patients with multiple healthcare needs, and the expansion of the Electronic Health Records Sharing System to enable smooth information transfer of patient records to achieve coordinated care.3 In mainland China, the ‘family doctor teams’ which are built on the national basic public health service package have been gradually translated into routine primary care practice.4 A typical team consists of one GP clinician and healthcare personnel including public health doctors, nurses, and if available and suitable, pharmacists and social workers. The teams are featured by a continuous relationship between service providers and service users, thereby enhancing the provision of a core set of preventive care including health assessment, health-promoting interventions, health advice, and when necessary, home visits. Health issues related to the efficiency of care, control of chronic diseases, and quality of services from users’ perspectives have gained increasing attention.5
 
In this issue of the Hong Kong Medical Journal, Shi et al6 explore the utilisation pattern of village clinics in rural areas and investigate the clinical competence of rural primary care providers through a survey study conducted in Southwestern China. Significant gaps were identified in service provision between ethnic groups, which may be explained by the suboptimal clinical competence of ethnic minority providers. The study carries implications for upscaling system-level inputs to enhance the clinical capacity of rural primary care personnel through government-level actions to ensure adequate in-service training and professional development in remote and deprived areas. It also provides impetus for developing integrated competency-based GP training systems for village clinicians, which could then be translated into improved accessibility to and process of primary care, thereby leading to sustainable health promotion and disease prevention.
 
Nevertheless, multisectoral efforts to strengthen capacity building in rural primary care would also require attention paid to address barriers to strong motivation and active commitment to the provision of care in rural practice given the possible existence of clinical inertia and workload-related factors. A recent multicentre study conducted among rural primary care physicians across four provinces in China demonstrated physician-level challenges to the attainment of the target frequency of follow-up care for hypertension and diabetes—the two most common long-term conditions in the community.7 Ethnic minorities, or those who live in rural areas of high socio-economic deprivation, tend to encounter greater physician-level barriers to optimal care such as inadequate healthcare capacity and limited availability of qualified professionals. This may be due to insufficient clinical resources and the physician’s inherent pursuit of advanced medical technology, higher remuneration, and better career prospect in more affluent areas. Meanwhile, individual-level barriers such as financial burden, lack of social support, fearful emotions, negative health beliefs, underestimation of concomitant risks, and unfavourable cultural preferences may also inhibit the routine utilisation of healthcare services in low-income areas. In real-world settings, longitudinal observations manifest difficulties in maintaining long-term improvement of clinical parameters in chronically ill patients in the absence of actively provided and continuous health education support.8 Previous investigations conducted in eastern, central, and western rural China have highlighted the importance of effective provider-patient communication, which is, however, relatively poor during clinical encounters in rural primary care practice.9 These barriers may act together, rather than in isolation, to hinder the personalisation and prioritisation of care, resulting in exacerbated health and social disparities in areas of high socio-economic deprivation.10
 
From the perspective of health services research, the physician-patient encounter is a reflection of the care process, which takes into account patient needs and health expectations. A recent multi-centre primary care assessment demonstrated significant associations between improvement in patients’ experiences and reduced treatment burden.4 Structural efforts to improve the process of care emphasise the need to strengthen capacity building within, with and around primary care multidisciplinary teams in joint decision-making and problem-solving.11 Such approaches carry the potential to enable a combination of care regimes based on effective health education to ensure patient engagement across the care continuum, leading to improved patient experiences and population health.12
 
International consensus has been reached on the contribution of high-quality primary care to better population health outcomes in a cost-effective manner. This offers improvements in health equity, greater efficiency in chronic disease management, avoidance of preventable hospitalisation and emergency room visits, and better quality of life. Nowadays, primary care plays a central role in delivering both patient-centred and population-oriented services for long-term conditions, for instance, the screening for diabetes.13 Of equal importance is eye health for those diagnosed with diabetes to prevent vision loss. Similarly, promoting and improving eye health also requires systematic actions to address a wide range of protective and risk factors at all stages of life, starting from as early as the preconception and prenatal stage, through infancy and early childhood to adolescence, and into adulthood and older age. To further this objective, the World Health Organization is calling for increased emphasis on reorienting the model of care towards an integrated, people-centred approach for eye health based on strong primary care.14
 
Local experiences have demonstrated the crucial role of well-trained primary care physicians in infectious disease control, performance measurement, and emergency response as an integral part of the surveillance system in dealing with outbreaks of severe acute respiratory syndrome (SARS), H1N1 influenza, and coronavirus disease 2019 (COVID-19).15 16 So-called ‘long covid’ poses additional challenges for delivering tailored health and educational services to children and families.17 In response to the ever-increasing healthcare need due to complex conditions and circumstances, more work is needed in the study of digital technologies for health, lifestyle management strategies from the perspective of complementary and alternative medicine,18 and research instruments that capture key attributes of primary care to monitor the extent to which equitable care is achieved.19 Meanwhile, endeavours to promote workforce wellbeing and prevent primary care practitioners from stress, burnout, and depression are of vital importance.20 Empirical evidence from studies on innovative models of service delivery in real-world settings would better inform policy decisions and prioritisations to meet the health aims and move the health system towards a more people-centred approach of service delivery over time in areas of different socio-economic status.
 
Author contributions
All authors contributed to the editorial, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have declared no conflict of interest.
 
References
1. World Health Organization and United Nations Children’s Fund (UNICEF). Operational Framework for Primary Health Care: Transforming Vision into Action. Geneva: World Health Organization; 2020.
2. Stewart E, Donaghy E, Guthrie B, et al. Transforming primary care in Scotland: a critical policy analysis. Br J Gen Pract 2022;72:292-4.Crossref
3. Ho MK. Strengthening primary care in Hong Kong: fostering continuity of care from a health system perspective. Hong Kong Med J 2020;26:543-5. Crossref
4. Hu XJ, Wang HH, Li YT, et al. Healthcare needs, experiences and treatment burden in primary care patients with multimorbidity: an evaluation of process of care from patients’ perspectives. Health Expect 2022;25:203-13. Crossref
5. Wong MC, Huang J, Xu W, et al. Research for health issues in mainland China—a growing need unaddressed. Hong Kong Med J 2020;26:4-5. Crossref
6. Shi Y, Song S, Peng L, et al. Utilisation of village clinics in Southwestern China: evidence from Yunnan Province. Hong Kong Med J 2022;28:306-14. Crossref
7. Wang Y, Hu XJ, Wang HH, et al. Follow-up care delivery in community-based hypertension and type 2 diabetes management: a multi-centre, survey study among rural primary care physicians in China. BMC Fam Pract 2021;22:224. Crossref
8. Hu XJ, Wu HF, Li YT, et al. Influence of health education on clinical parameters in type 2 diabetic subjects with and without hypertension: a longitudinal, comparative analysis in routine primary care settings. Diabetes Res Clin Pract 2020;170:108539. Crossref
9. Zhou Q, An Q, Wang N, et al. Communication skills of providers at primary healthcare facilities in rural China. Hong Kong Med J 2020;26:208-15. Crossref
10. Wang HH, Mercer SW. Understanding barriers to adherence to optimal treatment of elevated blood pressure and hypertension-insights from primary care. JAMA Netw Open 2021;4:e2138651. Crossref
11. Wang HH. Taking a multidisciplinary team approach to better healthcare outcomes for society. Hong Kong Med J 2020;26:551-2. Crossref
12. Wang HH, Li YT, Wong MC. Leveraging the power of health communication: messaging matters not only in clinical practice but also in public health. Hong Kong Med J 2022;28:103-5. Crossref
13. Wong MC, Huang J, Kong AP. Diabetes screening revisited: issues related to implementation. Hong Kong Med J 2020;26:283-5. Crossref
14. World Health Organization. World Report on Vision. Geneva: World Health Organization; 2019.
15. Poon PK, Wong SY. Primary care doctors and the control of COVID-19. Hong Kong Med J 2021;27:86-7. Crossref
16. Yu EY, Leung WL, Wong SY, Liu KS, Wan EY; HKCFP Executive and Research Committee. How are family doctors serving the Hong Kong community during the COVID-19 outbreak? A survey of HKCFP members. Hong Kong Med J 2020;26:176-83. Crossref
17. Tse WW, Kwan MY. Impacts of the COVID-19 pandemic on the physical and mental health of children. Hong Kong Med J 2021;27:175-6. Crossref
18. Wang Y, Wu XY, Wang HH, et al. Body constitution and unhealthy lifestyles in a primary care population at high cardiovascular risk: new insights for health management. Int J Gen Med 2021;14:6991-7001. Crossref
19. Wang HH, Wong SY, Wong MC. Attributes of primary care in community health centres in China and implications for equitable care: a cross-sectional measurement of patients’ experiences. QJM 2015;108:549-60. Crossref
20. Kwan KY, Chan LW, Cheng PW, Leung GK, Lau CS. Burnout and well-being in young doctors in Hong Kong: a territory-wide cross-sectional survey. Hong Kong Med J 2021;27:330-7. Crossref

Management of chronic musculoskeletal pain in Hong Kong

© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
EDITORIAL
Management of chronic musculoskeletal pain in Hong Kong
Regina WS Sit, FHKAM (Family Medicine), MD1; SW Law, MB, ChB, FHKAM (Orthopaedic Surgery)2,3; CY Lam, FHKAM (Orthopaedic Surgery), MPH4; Martin CS Wong, MD, MPH1
1 The JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong
2 Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong
3 The Hong Kong College of Orthopaedic Surgeons, Hong Kong
4 Department of Orthopaedics and Traumatology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
 
Corresponding author: Dr Regina WS Sit (reginasit@cuhk.edu.hk)
 
 Full paper in PDF
 
Chronic musculoskeletal pain is a common and disabling condition, with significant physical, psychological, and social impairments.1 According to the Census and Statistics Department of the Hong Kong Special Administrative Region, it is estimated that the number of Hong Kong residents aged ≥65 years will increase from 0.9 million in 2011 (13% of the population) to around 2.6 million in 2041 (30% of the projected population).2 A local study in 2016 reported the prevalence of chronic pain of 28.7% in the general population; 83.1% reported more than one site of pain, and 5.8% reported eight or more sites of pain around the body.3 The prevalence is higher in the older population, with 70% adults aged ≥60 years reported having chronic pain of moderate intensity; the most common sites were the knee (48.3%), back (34.7%), and shoulder (28.1%).4 It is expected that individual and socio-economic burdens of chronic musculoskeletal pain will increase with the ageing population in Hong Kong, requiring a multi-level integrated response.
 
Management of chronic musculoskeletal pain in Hong Kong
Chronic musculoskeletal pain is commonly encountered in primary care.5 The role of primary care physicians is to assess, to diagnose and to manage treatable and modifiable causes. They also act as gatekeepers, identifying suitable candidates for secondary care. More importantly, primary care physicians help individuals with chronic pain to maintain the optimal quality of life.6 Chronic musculoskeletal pain, whether a result of trauma, infection, tumours, or other orthopaedic conditions with surgical implications, is managed by orthopaedic surgeons. For refractory pain, patients will be referred to pain clinics for more invasive interventions such as nerve blocks or spinal injections.7 The majority of residents in Hong Kong have Chinese ethnicity, so traditional Chinese medicine also plays an important role in the care of chronic musculoskeletal pain with treatments such as acupuncture and joint manipulation.8 Other allied health professionals, such as physiotherapists, occupational therapists, pain nurses, dietitians, psychologists, pharmacists, prosthetists, and orthotists also contribute substantially to the management and rehabilitation of various chronic musculoskeletal pain conditions. Despite having groups of experts in different fields in Hong Kong, there are major challenges to pain care, including over-reliance on the biomedical view of pain, inadequate emphasis on the biopsychosocial approach, a lack of service models to streamline communication, and a lack of cooperation and collaboration among disciplines.
 
Multidisciplinary care for chronic musculoskeletal pain
As healthcare systems internationally and in Hong Kong shift from promoting biomedical models of chronic pain to biopsychosocial models, multidisciplinary or interdisciplinary pain management models are encouraged.9 The team consists of multiple health providers from different disciplines with sufficient professional breadth that integrates through frequent communication and common goals to comprehensively address the biopsychosocial model of pain.10 The treatment- and cost-effectiveness of such pain management programmes have been well documented in the scientific literature, and their implementations have been successful.11 However, most of these programmes have been operated either in secondary or even tertiary care, where pain conditions are already chronic, complicated, and refractory. Therefore, we believe effective models of care should also be implemented in primary care. Timely and comprehensive management initiated in primary care can potentially avoid the course of development into chronicity. One example is “Turning Pain into Gain”,12 a multidisciplinary chronic pain programme implemented in one of the Primary Health Network in South East Queensland, Australia. This programme resulted in significant improvements in medication management, participant self-efficacy, and self-reported hospitalisations.12
 
Newer concepts for model development
The traditional model of medicine and medical science, which attempts to attribute musculoskeletal symptoms to a pathological diagnosis, has hindered the development of a more rational and effective approach to chronic pain care. This approach considers pain as the only guide to the underlying pathology and overemphasises diagnosis and attempts at cure. This approach ignores the status of pain and its related disability which warrant assessment and management of its own.13 There is a conceptual shift to place symptoms and their impact on daily life at the centre of primary care management.14 Furthermore, care should focus on individuals with co-morbidity rather than a distinctive single musculoskeletal diagnosis, incorporating psychological and social context in the management.15 Musculoskeletal pain is almost inevitable in the lifetime of an individual,16 and the resulting disability may diminish the opportunity for active and positive approaches to care. Therefore, promotion of active self-management, exercise and positive thinking are essential in supporting individuals with chronic pain.17 18 Platforms that facilitate communication between physicians, surgeons, and allied healthcare professionals enhance knowledge exchange and ultimately improve chronic pain care.19 Because managing chronic musculoskeletal pain is one of the largest workloads in primary care, knowledge, training, and enthusiasm must be strengthened.6 14 Other directions are possible alternatives, such as supporting and training healthcare professionals other than doctors to undertake the role of gatekeeper, such as permitting direct access for patients to advice from physiotherapists and pharmacists. These could be especially effective in areas where access to medical care is difficult.20 21
 
Reference framework of chronic musculoskeletal management in primary care
In addition to shifts in focus from unidisciplinary to multidisciplinary care, from passive treatment to active self-management, and from the complete cure of pain to living with the pain, another important change is from secondary to primary care. Primary care management should be holistic and evidence-based. Recent high-quality guidelines are available; however, there continues to be a relative lack of high-quality primary care–focused research in chronic pain. Further education, research, and resourcing targeted at primary care management of chronic pain are required to ensure efficient and effective evidence-based care. To facilitate all these, a task force formed by a group of experts is now working on a new reference framework for chronic musculoskeletal pain management in primary care settings. This reference framework aims to identify guidelines, models, and projects that represent the most comprehensive approach to managing chronic musculoskeletal pain, using the best available evidence that is relevant to the local healthcare context. The framework will determine successful elements in treating chronic musculoskeletal pain, as well as preventive strategies and blueprints for the promotion of overall musculoskeletal health.
 
Author contributions
All authors contributed to the Editorial, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Funding/support
This editorial received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
 
References
1. Cimmino MA, Ferrone C, Cutolo M. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 2011;25:173-83. Crossref
2. Hong Kong Population Projections 2015-2064. Census and Statistics Department, Hong Kong SAR Government; 2015.
3. Cheung CW, Choi SW, Wong SS, Lee Y, Irwin MG. Changes in prevalence, outcomes, and help-seeking behavior of chronic pain in an aging population over the last decade. Pain Pract 2017;17:643-54. Crossref
4. Sit RW, Zhang D, Wang B, et al. Sarcopenia and chronic musculoskeletal pain in 729 community-dwelling Chinese older adults with multimorbidity. J Am Med Dir Assoc 2019;20:1349-50. Crossref
5. Mose S, Kent P, Smith A, Andersen JH, Christiansen DH. Trajectories of musculoskeletal healthcare utilization of people with chronic musculoskeletal pain—a population-based cohort study. Clin Epidemiol 2021;13:825-43. Crossref
6. Mills S, Torrance N, Smith BH. Identification and management of chronic pain in primary care: a review. Curr Psychiatry Rep 2016;18:22. Crossref
7. Chu MC, Law RK, Cheung LC, et al. Pain management programme for Chinese patients: a 10-year outcome review. Hong Kong Med J 2015;21:304-9. Crossref
8. Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain 2018;19:455-74. Crossref
9. Gatchel RJ, McGeary DD, McGeary CA, Lippe B. Interdisciplinary chronic pain management: past, present, and future. Am Psychol 2014;69:119-30. Crossref
10. Stanos S, Houle TT. Multidisciplinary and interdisciplinary management of chronic pain. Phys Med Rehabil Clin N Am 2006;17:435-50. Crossref
11. Kamper SJ, Apeldoorn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ 2015;350:h444. Crossref
12. Joypaul S, Kelly FS, King MA. Turning pain into gain: evaluation of a multidisciplinary chronic pain management program in primary care. Pain Med 2019;20:925-33. Crossref
13. Clauw DJ, Essex MN, Pitman V, Jones KD. Reframing chronic pain as a disease, not a symptom: rationale and implications for pain management. Postgrad Med 2019;131:185-98. Crossref
14. Croft P, Peat GM, Van Der Windt DA. Primary care research and musculoskeletal medicine. Prim Health Care Res Dev 2010;11:4-16. Crossref
15. Bergman S. Management of musculoskeletal pain. Best Pract Res Clin Rheumatol 2007;21:153-66. Crossref
16. Walsh NE, Brooks P, Hazes JM, et al. Standards of care for acute and chronic musculoskeletal pain: the Bone and Joint Decade (2000-2010). Arch Phy Med Rehabil 2008;89:1830-45. Crossref
17. Du S, Yuan C, Xiao X, Chu J, Qiu Y, Qian H. Self-management programs for chronic musculoskeletal pain conditions: a systematic review and meta-analysis. Patient Educ Couns 2011;85:e299-310. Crossref
18. Reid MC, Papaleontiou M, Ong A, Breckman R, Wethington E, Pillemer K. Self-management strategies to reduce pain and improve function among older adults in community settings: a review of the evidence. Pain Med 2008;9:409-24. Crossref
19. Gordon DB, Watt-Watson J, Hogans BB. Interprofessional pain education—with, from, and about competent, collaborative practice teams to transform pain care. Pain Rep 2018;3:e663. Crossref
20. Bury TJ, Stokes EK. A global view of direct access and patient self-referral to physical therapy: implications for the profession. Phys Ther 2013;93:449-59. Crossref
21. Hadi MA, Alldred DP, Briggs M, Munyombwe T, José Closs S. Effectiveness of pharmacist-led medication review in chronic pain management: systematic review and meta-analysis. Clin J Pain 2014;30:1006-14. Crossref

Cardiovascular complications of COVID-19: a future public health burden requiring intensive attention and research

© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
EDITORIAL
Cardiovascular complications of COVID-19: a future public health burden requiring intensive attention and research
Bryan P Yan, MB, BS, MD1; Martin CS Wong, MD, MPH2,3
1 Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
2 JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
3 Editor-in-Chief, Hong Kong Medical Journal
 
Corresponding author: Prof Martin CS Wong (wong_martin@cuhk.edu.hk)
 
 Full paper in PDF
 
Although coronavirus disease 2019 (COVID-19) is primarily a respiratory disease, cardiovascular complications are frequent in patients with COVID-19 and are associated with poor prognosis.1 Myocardial injury, defined as elevation of serum troponin level, is one of the most common extrapulmonary complications of COVID-19.2 The incidence of cardiac injury increases with severity of disease (62.9% in severe cases vs 17.9% in mild),2 and with age (4% <60 years vs 12.5% 60-74 years vs 31% ≥75 years in age).3 Elevated troponin levels are associated with increased intensive care unit admission and worse prognosis.4 5 As the COVID-19 pandemic evolves and variants emerge, a clear understanding regarding the short- and long-term effects of COVID-19 on the cardiovascular system and outcomes is urgently needed.
 
In this issue of Hong Kong Medical Journal, Lo et al6 review the literature on cardiac injury associated with COVID-19. This review is both timely and important for us to better understand the pathogenesis of cardiac injury and the implications for treatment. Most studies included in this review reported cardiovascular complications during the acute phase of infection; however, recent data have shown that COVID-19 can cause cardiovascular symptoms, such as shortness of breath and palpitations. These symptoms can last weeks or months after the infection has gone. This is sometimes called post-COVID-19 syndrome or “long COVID”.7 A recent study has shown that the risk and 1-year burden of cardiovascular disease, including cerebrovascular disorders, dysrhythmias, ischemic and non–ischaemic heart disease, pericarditis, myocarditis, heart failure, and thromboembolic disease in survivors of acute COVID-19 are substantial.7 Patients with severe COVID-19 who need to be admitted to hospital or intensive care unit are at higher risk; however, even people with mild disease who do not need hospitalisation are also at increased risk of cardiovascular diseases 6 months to 1 year later.7 There is still a lot to learn about the lasting effects COVID-19 has had on the heart. Among magnetic resonance imaging scans of patients who recovered from COVID-19, the majority (78/100) showed abnormal findings suggestive of ongoing inflammation and scarring on the heart muscle.8 The virus may leave behind lasting heart damage that needs monitoring in some patients.
 
Since the emergence of the new Omicron variant in November 2021, experts have been trying to learn more about this variant and the risks it poses in the long term. The Omicron variant is highly transmissible which might mean an increase in cases, leading to more hospitalisations, cardiovascular complications, and deaths. The long-term cardiovascular effects of this variant are less well understood and are yet be addressed.
 
Physicians should consider a history of COVID-19 as a cardiovascular disease risk. It is important to identify early signs or symptoms of heart disease in these people. Early detection, diagnosis, and treatment will be key to prevent downstream adverse cardiovascular consequences. There are a lot of knowledge gaps that need to be investigated in future research to gain a better understanding of long-term cardiovascular outcomes of patients with COVID-19. How best to identify, diagnose, and treat these patients is a critical area of future research. The long-term trajectory of cardiovascular diseases among patients with COVID-19 requires long-term cohort studies to guide clinical practice and inform public health policy. An important message is increased awareness of cardiovascular complications among patients with COVID-19 and having well-established follow-up strategies.
 
Author contributions
All authors contributed to the editorial, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
The authors have declared no conflict of interest.
 
References
1. Welty FK, Rajai N, Amangurbanova M. Comprehensive review of cardiovascular complications of coronavirus disease 2019 and beneficial treatments. Cardiol Rev 2022;30:145-57. Crossref
2. Li T, Lu L, Zhang W, et al. Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China. Arch Gerontol Geriatr 2020;91:104185. Crossref
3. Zhao M, Wang M, Zhang J, et al. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages. Aging (Albany NY) 2020;12:10070-86. Crossref
4. Lala A, Johnson KW, Januzzi JL, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol 2020;76:533-46. Crossref
5. Ni W, Yang X, Liu J, et al. Acute myocardial injury at hospital admission is associated with all-cause mortality in COVID-19. J Am Coll Cardiol 2020;76:124-5. Crossref
6. Lo YS, Jok C, Tse HF. Cardiovascular complications of COVID-19. Hong Kong Med J 2022;28:249-56. Crossref
7. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022;28:583-90. Crossref
8. Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:1265-73. Crossref

COVID-19 pandemic after Omicron

© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
EDITORIAL
COVID-19 pandemic after Omicron
Christopher KC Lai, FHKCPath, FHKAM (Pathology)1; Wilson Lam, FRCP, FHKAM (Medicine)2; KY Tsang, FRCP (Edin), FHKAM (Medicine)3; Frankie WT Cheng, FRCPCH, MD4; Martin CS Wong, MD, MPH5,6
1 Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
2 Chiron Medical, Hong Kong
3 Specialist in Infectious Disease, Private Practice, Hong Kong
4 Department of Paediatrics and Adolescent Medicine, Hong Kong Children’s Hospital, Hong Kong
5 JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
6 Editor-in-Chief, Hong Kong Medical Journal
 
Corresponding author: Prof Martin CS Wong (wong_martin@cuhk.edu.hk)
 
 Full paper in PDF
 
At the time of writing, the “fifth wave” of coronavirus disease 2019 (COVID-19) in Hong Kong that started to surge since late January 2022 is receding. The fifth wave has been the worst so far, with daily cases exceeding 55 000, and total >9000 deaths.1 Epidemiological studies predicted that 4.5 to 5 million people in Hong Kong would have contracted COVID-19 by the end of the wave.2 However, as the pandemic progresses, more people will gain immunity against the virus through vaccination or natural infection, or both (hybrid immunity). Together with a community-wide intersectoral effort to boost vaccination uptake, the COVID-naïve population in Hong Kong will decline rapidly, and so will the transmission efficiency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It seems we are set to cruise back to pre-COVID normalcy. Or are we?
 
Since its emergence in late 2019, SARS-CoV-2 has mutated at an astounding rate. Omicron has evolved to be the most transmissible variant so far, fortunately causing less severe disease than its predecessors.3 Will Omicron stay as the predominant variant, or will new variants emerge causing fresh waves? Despite the waning of the current Omicron wave, SARS-CoV-2 continues to spread in almost every corner of the world. The huge number of infections has provided near ideal conditions for new variants to emerge, as we have seen in the Delta4 and Omicron variants.5 One of the latest recombinants of Omicron BA.1 and BA.2 strain known as XE is even more transmissible than Omicron BA.2.6 It seems likely that we are set to be challenged by more new variants, albeit with some degree of protection from immunity generated during previous infection or vaccination. Given that the virus is unlikely to disappear completely, COVID-19 will inevitably become an endemic disease. The COVID-19 vaccines are now well known to significantly lower disease severity and mortality, and have saved millions of lives worldwide. Despite the proven efficacy and safety profile, vaccine hesitancy remains a concern.7 Moreover, it is now increasingly evident that COVID-19 vaccines are not going to halt the pandemic. Infections still occur in fully vaccinated individuals,8 and antibody level is known to decrease over time.9
 
In the past 2 years, the Hong Kong Medical Journal has published >60 COVID-19-related papers. We foresee that the need for COVID-19-related studies will remain. Future research directions will be realigned as the pandemic unfolds, with vaccine-related research in the highest demand. In 2021, the Journal published a serological response to mRNA and inactivated vaccines in healthcare workers in Hong Kong,10 and reported cases of myocarditis and pericarditis after mRNA vaccines.11 New vaccines in novel platforms or targeting new COVID-19 variants will continue to be developed, and research directed at monitoring the efficacy and adverse effects of these vaccines will remain important to guide vaccination strategies. Vaccine hesitancy remains a major hurdle in achieving herd immunity,7 12 and public health intervention studies involving various stakeholders in the community that can promote vaccine uptake will be highly sought.
 
In the earliest months of pandemic, the Journal published radiological findings of critically ill patients diagnosed with COVID-19,13 and a case series on contrasting evidence for corticosteroid treatment for COVID-19-induced cytokine storm in children.14 We anticipate publications on clinical management will remain invaluable to the medical community, perhaps with a shift in focus to greater emphasis on integrative treatment strategies,15 microbiome-based therapies, and prophylactic antiviral agents and monoclonal antibody therapies targeting vulnerable populations such as the paediatric population16 17 and immunocompromised hosts.
 
In 2021, the Journal published an editorial by Tse et al18 on the impact of COVID-19 on both physical health and mental health. We anticipate the need for further research in the areas of mental health and mental well-being during the COVID-19 pandemic.
 
Many COVID-19 survivors report persistence of symptoms after recovery. With an estimate of 4 to 5 million of the Hong Kong population infected with COVID-19,2 it is clear that more resources should be allocated to long COVID–related services and research. Systematic gathering of information on long COVID will allow accurate measurement of the disease burden and will be critical in facilitating future research. Establishment of designated one-stop multidisciplinary medical centres will allow individualised treatment and rehabilitation programmes, optimising the care of long COVID sufferers and providing a positive impact at the societal level. We will witness researchers moving from studying acute COVID infections to studying post-COVID-19 conditions in the near future.
 
Laboratory diagnostics played a crucial role in COVID-19 case findings, contact tracing, and outbreak investigations. Throughout the course of the COVID-19 pandemic we have witnessed the widespread use of state-of-the-art next-generation sequencing techniques in understanding the phylogeny and evolution of SARS-CoV-2.19 20 However, novelty does not necessarily require high-tech gadgets; a study by Zee et al21 illustrated how the use of rapid antigen tests can assist outbreak control in a hospital. With the rapid development of new laboratory techniques and novel ideas, we expect a huge amount of knowledge to be generated in this area.
 
Epidemiology and public health studies with forecasting ability can guide public policies. The Journal has published research articles on experiences of a temporary testing centre at the AsiaWorld-Expo,22 department-level contingency plans for contact tracing and facility management,23 and admission triage for adult intensive care.24
 
The waning fifth COVID wave gives us much-needed breathing space to plan ahead. We have faced challenges in ensuring that the Hong Kong population is protected by vaccination and effective testing and tracing. We have experienced global supply chain disruption in key pandemic products, including vaccines, antivirals, personal protective equipment, and laboratory test kits and reagents. It is time to reflect on what we could have done if we knew COVID was coming, and to make it a reality for future pandemics. Pandemic preparedness requires a holistic approach from multiple disciplines to provide a comprehensive and generalisable preparedness plan.25 A recent article by Morens et al26 suggested that “controlling COVID-19 by increasing herd immunity may be an elusive goal”. Research focusing on infectious disease epidemiology, public health policies, laboratory diagnostics, vaccine development, and drug discovery will remain in high demand. Future research will need to be synergistic and able to coalesce into a strong healthcare system, to defend against subsequent COVID waves and future pandemics.
 
Author contributions
All authors contributed to the Editorial, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Funding/support
This editorial received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
 
Conflicts of interest
The authors have declared no conflict of interest.
 
References
1. Centre for Health Protection of the Department of Health; and the Hospital Authority. Statistics on 5th wave of COVID-19. 27 April 2022. Available from: https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf. Accessed 28 Apr 2022.
2. The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong. Assessment of Omicron outbreak in Hong Kong. 20 April 2022. Available from: https://www.sphpc.cuhk.edu.hk/post/study-assessment-of-omicron-outbreak-in-hong-kong. Accessed 28 Apr 2022.
3. Centers for Disease Control and Prevention. Omicron variant: what you need to know. 29 March 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/variants/omicron-variant.html. Accessed 28 Apr 2022.
4. Ferreira IA, Kemp SA, Datir R, et al. SARS-CoV-2 B.1.617 mutations L452R and E484Q are not synergistic for antibody evasion. J Infect Dis 2021;224:989-94. Crossref
5. Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature 2021;600:21. Crossref
6. UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England. 25 March 2022 (updated 8 April 2022). Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067672/Technical-Briefing-40-8April2022.pdf. Accessed 28 Apr 2022.
7. Chan PK, Wong MC, Wong EL. Vaccine hesitancy and COVID-19 vaccination in Hong Kong. Hong Kong Med J 2021;27:90-1. Crossref
8. Bergwerk M, Gonen T, Lustig Y, et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med 2021;385:1474-84. Crossref
9. Lin DY, Zeng D, Gu Y, Krause PR, Fleming TR. Reliably assessing duration of protection for COVID-19 vaccines. J Infect Dis 2022 Apr 21;jiac139. Epub ahead of print. Crossref
10. Zee JS, Lai KT, Ho MK, et al. Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: decline in antibodies 12 weeks after two doses. Hong Kong Med J 2021;27:380-3. Crossref
11. Kwan MY, Chua GT, Chow CB, et al. mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J 2021;27:326-7. Crossref
12. Chau CY. COVID-19 vaccination hesitancy and challenges to mass vaccination. Hong Kong Med J 2021;27:377-9. Crossref
13. Woo SC, Yung KS, Wong T, et al. Imaging findings of critically ill patients with COVID-19 pneumonia: a case series. Hong Kong Med J 2020;26:236-9. Crossref
14. Leung KK, Hon KL, Qian SY, Cheng FW. Contrasting evidence for corticosteroid treatment for coronavirusinduced cytokine storm. Hong Kong Med J 2020;26:269-71. Crossref
15. Lin WL, Hon KL, Leung KK, Lin ZX. Roles and challenges of traditional Chinese medicine in COVID-19 in Hong Kong. Hong Kong Med J 2020;26:268-9. Crossref
16. Hon KL, Leung KK. Paediatrics is a big player of COVID-19 in Hong Kong. Hong Kong Med J 2020;26:265-6. Crossref
17. Chua GT, Wong JS, Chung J, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2: a case report. Hong Kong Med J 2022;28:76-8. Crossref
18. Tse WW, Kwan MY. Impacts of the COVID-19 pandemic on the physical and mental health of children. Hong Kong Med J 2021;27:175-6. Crossref
19. Chen Z, Chong KC, Wong MC, et al. A global analysis of replacement of genetic variants of SARS-CoV-2 in association with containment capacity and changes in disease severity. Clin Microbiol Infect 2021;27:750-7. Crossref
20. Siu GK, Lee LK, Leung KS, et al. Will a new clade of SARS-CoV-2 imported into the community spark a fourth wave of the COVID-19 outbreak in Hong Kong? Emerg Microbes Infect 2020;9:2497-500.Crossref
21. Zee JS, Chan CT, Leung AC, et al. Rapid antigen test during a COVID-19 outbreak in a private hospital in Hong Kong. Hong Kong Med J 2022 Mar 17. Epub ahead of print. Crossref
22. Leung WL, Yu EL, Wong SC, et al. Findings from the first public COVID-19 temporary test centre in Hong Kong. Hong Kong Med J 2021;27:99-105. Crossref
23. Mak ST, Fung KS, Li KK. Formulation of a departmental COVID-19 contingency plan for contact tracing and facilities management. Hong Kong Med J 2021;27:148-9. Crossref
24. Joynt GM, Leung AK, Ho CM, et al. Admission triage tool for adult intensive care unit admission in Hong Kong during the COVID-19 outbreak. Hong Kong Med J 2022;28:64-72. Crossref
25. Wong AT, Chen H, Liu SH, et al. From SARS to avian influenza preparedness in Hong Kong. Clin Infect Dis 2017;64(suppl_2):S98-S104. Crossref
26. Morens DM, Folkers GK, Fauci AS. The concept of classical herd immunity may not apply to COVID-19. J Infect Dis 2022 Mar 31;jiac109. Epub ahead of print. Crossref

Kidney Health for All: bridging the gap in kidney health education and literacy

Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
EDITORIAL
Kidney Health for All: bridging the gap in kidney health education and literacy
Robyn G Langham, MB, BS, PhD1 #; Kamyar Kalantar-Zadeh, MD, PhD2 #; Ann Bonner, RN, PhD3; Alessandro Balducci, MD4 #; LL Hsiao, MD, PhD5 #; Latha A Kumaraswami, BA6 #; Paul Laffin, MS7 #; Vassilios Liakopoulos, MD, PhD8 #; Gamal Saadi, MD9 #; Ekamol Tantisattamo, MD, MPH2; Ifeoma Ulasi, MB, BS, MSc10 #; SF Lui, MD11 #; for the World Kidney Day Joint Steering Committee#
1 St Vincent’s Hospital, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia
2 Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine, Orange, California, United States
3 School of Nursing and Midwifery, Griffith University, Southport, Queensland, Australia
4 Italian Kidney Foundation, Rome, Italy
5 Brigham and Women’s Hospital, Renal Division, Department of Medicine, Boston, Massachusetts, United States
6 Tamilnad Kidney Research (TANKER) Foundation, The International Federation of Kidney Foundations–World Kidney Alliance (IFKF–WKA), Chennai, India
7 International Society of Nephrology, Brussels, Belgium
8 Division of Nephrology and Hypertension, First Department of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
9 Nephrology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt
10 Renal Unit, Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Nigeria
11 International Federation of Kidney Foundations–World Kidney Alliance, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong
# Members of the World Kidney Day Steering Committee
 
Corresponding author: Dr Robyn G Langham (rlangham@unimelb.edu.au)
 
 Full paper in PDF
 
Abstract
The high burden of kidney disease, global disparities in kidney care, and poor outcomes of kidney failure bring a concomitant growing burden to persons affected, their families, and carers, and the community at large. Health literacy is the degree to which persons and organisations have or equitably enable individuals to have the ability to find, understand, and use information and services to make informed health-related decisions and actions for themselves and others. Rather than viewing health literacy as a patient deficit, improving health literacy largely rests with healthcare providers communicating and educating effectively in codesigned partnership with those with kidney disease. For kidney policy makers, health literacy provides the imperative to shift organisations to a culture that places the person at the centre of healthcare. The growing capability of and access to technology provides new opportunities to enhance education and awareness of kidney disease for all stakeholders. Advances in telecommunication, including social media platforms, can be leveraged to enhance persons’ and providers’ education; The World Kidney Day declares 2022 as the year of “Kidney Health for All” to promote global teamwork in advancing strategies in bridging the gap in kidney health education and literacy. Kidney organisations should work towards shifting the patient-deficit health literacy narrative to that of being the responsibility of healthcare providers and health policy makers. By engaging in and supporting kidney health–centred policy making, community health planning, and health literacy approaches for all, the kidney communities strive to prevent kidney diseases and enable living well with kidney disease.
 
Given the high burden of kidney disease and global disparities related to kidney care, in carrying forward our mission of advocating Kidney Health for All, the challenging issue of bridging the well-identified gap in the global understanding of kidney disease and its health literacy is the theme for World Kidney Day (WKD) 2022. Health literacy is defined as the degree to which persons and organisations have—or equitably enable individuals to have—the ability to find, understand, and use information and services to inform health-related decisions and actions for themselves and others.1 Not only is there is growing recognition of the role that health literacy has in determining outcomes for persons affected by kidney disease and the community in general, but there is an emergent imperative for policy makers worldwide to be informed and cognizant of opportunities and real measurable outcomes that can be achieved through kidney-specific preventative strategies.
 
The global community of people with kidney disease
Most people are not aware of what kidneys are for or even where their kidneys are. For those afflicted by disease and the subsequent effects on overall health, effective healthcare provider communication is required to support individuals to be able to understand what to do, to make decisions, and to take action. Health literacy involves more than functional abilities of an individual; it is also the cognitive and social skills needed to gain access to, understand, and use information to manage health conditions.2 It is also contextual3 in that as health needs change, so too does the level of understanding and ability to problem solve alter. Health literacy is, therefore, an interaction between individuals, healthcare providers, and health policy makers.4 This is why the imperatives around health literacy are now recognised as indicators for the quality of local and national healthcare systems and healthcare professionals within them.5 For chronic kidney disease (CKD), as the disease progresses alongside other health changes and increasing treatment complexities, it becomes more difficult for individuals to manage.6 Promoted in health policy for around a decade involving care partnerships between health-centred policy, community health planning, and health literacy,7 current approaches need to be shifted forward (Table 1).
 

Table 1. Summary characteristic of kidney health promotion, involving kidney health–centred policy, community kidney health planning, and kidney health literacy, and proposed future direction
 
Assessing health literacy necessitates the use of appropriate multidimensional patient-reported measures, such as the World Health Organization–recommended Health Literacy Questionnaire (available in over 30 languages) rather than tools measuring only functional health literacy (eg, Rapid Estimate of Adult Literacy in Medicine or Short Test of Functional Health Literacy in Adults).8 It is therefore not surprising that studies of low health literacy (LHL) abilities in people with CKD have been demonstrated to be associated with poor CKD knowledge, self-management behaviours, and health-related quality of life and in those with greater co-morbidity severity.7 Unfortunately, most CKD studies have measured only functional health literacy, so the evidence that LHL results in poorer outcomes, particularly that it increases healthcare utilisation and mortality9 and reduces access to transplantation,10 is weak.
 
Recently, health literacy is now considered to be an important bridge between lower socioeconomic status and other social determinants of health.4 Indeed, this is not a feature that can be measured by the gross domestic product of a country, as the effects of LHL on the extent of CKD in the community are experienced globally regardless of country income status. The lack of awareness of risk factors of kidney disease, even in those with high health literacy abilities, is a testament to the difficulties in understanding this disease, and why the United States, for instance, recommends that a universal precautions approach towards health literacy is undertaken.11
 
So, what does the perfect health literacy programme look like for people with CKD? In several high-income countries, there are national health literacy action plans with the emphasis shifted to policy directives, organisational culture, and healthcare providers. In Australia, for instance, a compulsory health literacy accreditation standard makes the healthcare organisation responsible for ensuring providers are cognizant of individual health literacy abilities.12 Although many high-income countries, healthcare organisations, non-governmental organisations, and jurisdictions are providing an array of consumer-facing web-based programmes that provide detailed information and self-care training opportunities, most are largely designed for individual/family use that are unlikely to mitigate LHL. There is, however, substantial evidence that interventions improving healthcare provider communication are more likely to improve understanding of health problems and abilities to adhere to complex treatment regimens.13
 
Access to information that is authentic and tailored specifically to the needs of the individual and the community is the aim. The challenge is recognised acutely in more remote and low- to middle-income countries of the world, specifically the importance of culturally appropriate knowledge provision. The principles of improving health literacy are the same, but understanding how to proceed, and putting consumers in charge, with a co-design approach, is critical and may result in a different outcome in more remote parts of the world. This principle especially applies to communities that are smaller, with less access to electronic communication and healthcare services, where the level of health literacy is shared across the community and where what affects the individual also affects all the community. Decision support systems are different, led by elders, and in turn educational resources are best aimed at improving knowledge of the whole community.
 
A systematic review of the evaluation of interventions and strategies shows this area of research is still at an early stage,14 with no studies unravelling the link between LHL and poor CKD outcomes. The best evidence is in supporting targeted programmes on improving communication capabilities of healthcare professionals as central. One prime example is ‘teach-back’, a cyclical, simple, low-cost education intervention, which shows promise for improving communication, knowledge, and self-management in the CKD populations in low- or high-income countries.15 Furthermore, the consumer-led voice has articulated research priorities that align closely with principles felt to be important to the success of education: building new education resources, devised in partnership with consumers, and focussed on the needs of vulnerable groups. Indeed, programmes that address the lack of culturally safe, person-centred and holistic care, along with improving the communication skills of health professionals, are crucial for those with CKD.16
 
The networked community of kidney healthcare workers
Nonphysician healthcare workers, including nurses and advanced practice providers (physician assistants and nurse practitioners) as well as dietitians, pharmacists, social workers, technicians, physical therapists, and other allied health professionals, often spend more time with persons with kidney disease, compared with nephrologists and other physician specialists. In an ambulatory care setting at an appointment, in the emergency department, or in the in-patient setting, these healthcare professionals often see and relate to the patient first, last, and in between, given that physician encounters are often short and focused. Hence, the nonphysician healthcare workers have many opportunities to discuss kidney disease-related topics with the individuals and their care partners and to empower them.17 18 For instance, medical assistants can help identify those with or at risk of developing CKD and can initiate educating them and their family members about the role of diet and lifestyle modification for primary, secondary, and tertiary prevention of CKD while waiting to see the physician.19 Some healthcare workers provide networking and support for kidney patient advocacy groups and kidney support networks, which have been initiated or expanded via social media platforms (Fig 1).20 21 Studies examining the efficacy of social media in kidney care and advocacy are on the way.22 23
 

Figure 1. Schematic representation of consumer and healthcare professionals’ collaborative advocacy using social media platforms with the goal of ‘Kidney Health for All’
 
Like physicians, many activities of nonphysician healthcare workers have been increasingly affected by the rise of electronic health recording and growing access to internet-based resources, including social media, that offer educational materials related to kidney health, including kidney-preserving therapies with traditional and emerging interventions.24 These resources can be used for both self-education and for networking and advocacy on kidney disease awareness and learning. Increasingly, more healthcare professionals are engaged in some types of social media-based activities, as shown in Table 2. At the time of this writing, the leading social media used by many—but not all—kidney healthcare workers include Facebook, Instagram, Twitter, LinkedIn, and YouTube. In some regions of the world, certain social media are more frequently used than others given unique cultural or access constellations (eg, WeChat is a platform often used by healthcare workers and patient groups in China). Some healthcare professionals, such as managers and those in leadership and advocacy organisation positions, may choose to embark on social media to engage those with CKD and their care partners or other healthcare professionals in alliance building and marketing. To that end, effective communication strategies and outreach skills specific to responsible use of social media can provide clear advantages given that these skills and strategies are different and may need modification in those with LHL. It is imperative to ensure the needed knowledge and training for an accountable approach to social media is provided to healthcare providers, so that these outreach strategies are utilised with the needed awareness of their unique strengths and pitfalls, as follows.25
 

Table 2. Social media that are more frequently used for kidney education and advocacy
 
(i) Consumers’ and care partners’ confidentiality may not be breached upon posting anything on social media, including indirect referencing to a specific individual or a particular description of a condition unique to a specific person (eg, upon soliciting for transplant kidney donors on social media).26 27
ii) Confidential information about clinics, hospitals, dialysis centres, or similar healthcare and advocacy entities may not be disclosed on social media without ensuring that the needed processes, including collecting authorisations to disclose, are undertaken.
(iii) Healthcare workers’ job security and careers should remain protected with thorough review of the content of the messages and illustrations/videos before online posting.
(iv) Careless and disrespectful language and emotional tones are often counterproductive and may not be justified under the context of freedom of speech.
 
The global kidney community of policy and advocacy
Policy and advocacy are well-recognised tools that, if properly deployed, can bring about change and paradigm shift at the jurisdictional level. The essence of advocating for policy change to better address kidney disease is, in itself, an exercise in improving health literacy of the policy makers. Policy development, at its core, is a key stakeholder or stakeholder group (eg, the kidney community, which believes that a problem exists that should be tackled through governmental action). There is increasing recognition of the importance of formulating succinct, meaningful, and authentic information, akin to improving health literacy, to present to governments for action.
 
Robust and efficacious policy is always underpinned by succinct and applicable information; however, the development and communication of this message, designed to bridge the gap in knowledge of relevant jurisdictions, is only part of the process of policy development. An awareness of the process is important to clinicians who are aiming to advocate for effective change in prevention or improvement of outcomes in the CKD community.
 
Public policies, the plans for future action accepted by governments, are articulated through a political process in response to stakeholder observation, usually written as a directive, law, regulation, procedure, or circular. Policies are purpose fit and targeted to defined goals and specific societal problems and are usually a chain of actions effected to solve those societal problems.28 Policies are an important output of political systems. Policy development can be formal, passing through rigorous lengthy processes before adoption (such as regulations), or it can be less formal and quickly adopted (such as circulars). As already mentioned, the governmental action envisaged by the key stakeholders as a solution to a problem is at its core. The process enables stakeholders to air their views and bring their concerns to the fore. Authentic information that is meaningful to the government is critical. The policy development process can be stratified into five stages (ie, the policy cycle), as depicted by Anderson (1994)29 and adapted and modified by other authors30 (Fig 2). The policy cycle constitutes an expedient framework for evaluating the key components of the process.
 

Figure 2. Policy cycle involving five stages of policy development
 
Subsequently, the policy moves on to the implementation phase. This phase may require subsidiary policy development and adoption of new regulations or budgets (implementation). Policy evaluation is integral to the policy processes and applies evaluation principles and methods to assess the content, implementation, or impact of a policy. Evaluation facilitates understanding and appreciation of the worth and merit of a policy as well as the need for its improvement. More important, of the five principles of advocacy that underline policy making,31 the most important for clinicians engaged in this space is that of commitment, persistence, and patience. Advocacy takes time to yield the desired results.
 
The Advocacy Planning Framework, developed by Young and Quinn in 2002, 30 consists of overlapping circles representing three sets of concepts (way into the process, the messenger, and message and activities) that are key to planning any advocacy campaign:
 
(i) “Way into the process”: discusses the best approaches to translate ideas into the target policy debate and identify the appropriate audience to target.
(ii) Messenger: talks about the image maker or face of the campaign and other support paraphernalia that are needed.
(iii) Message and activities: describe what can be said to the key target audiences that is engaging and convincing. And how best it can be communicated through appropriate communication tools.
 
Advocacy is defined as “an effort or campaign with a structured and sequenced plan of action which starts, directs, or prevents a specific policy change.”31 The goal being to influence decision makers through communicating directly with them or getting their commitment through secondary audiences (advisers, the media, or the public) to the end that the decision maker understands, is convinced, takes ownership of the ideas, and finally has the compulsion to act.31 As with improving health literacy, it is the communication of ideas to policy makers for adoption and implementation as policy that is key. There is much to be done with bridging this gap in understanding of the magnitude of community burden that results from CKD. Without good communication, many good ideas and solutions do not reach communities and countries where they are needed. Again, aligned with the principles of developing resources for health literacy, the approach also needs to be nuanced according to the local need, aiming to have the many good ideas and solutions be communicated to communities and countries where they are needed
 
Advocacy requires galvanising momentum and support for the proposed policy or recommendation. The process is understandably slow as it involves discussions and negotiations for paradigms, attitudes, and positions to shift. In contemplating advocacy activities, multiple factors must be considered, interestingly not too dissimilar to that of building health literacy resources: What obstructions are disrupting the policy making process from making progress? What resources are available to enable the process to succeed? Is the policy objective achievable considering all variables? Is the identified problem already being considered by the policy makers (government or multinational organisations)? Any interest or momentum generated around it? Understandably, if there is some level of interest and if governments already have a spotlight on the issue, it is likely to succeed.
 
Approaches to choose from include the following31 32:
  • Advising (researchers are commissioned to produce new evidence-based proposals to assist the organisation in decision making).
  • Activism: involves petitions, public demonstrations, posters, fliers, and leaflet dissemination, often used by organisations to promote a certain value set.
  • Media campaign: having public pressure on decision makers helps in achieving results
  • Lobbying: entails face-to-face meetings with decision makers; often used by business organisations to achieve their purpose.
  •  
    Here lies the importance of effective and successful advocacy to stakeholders, including policy makers, healthcare professionals, communities, and key change makers in society. The WKD, since inception, has aimed at playing this role. World Kidney Day has gained people’s trust by delivering relevant and accurate messaging and supporting leaders in local engagement, and it is celebrated by kidney care professionals, celebrities, those with the disease, and their caregivers all over the world. To achieve the goal, an implementation framework of success in a sustainable way includes creativity, collaboration, and communication.
     
    The ongoing challenge for the International Society of Nephrology and International Federation of Kidney Foundations—World Kidney Alliance, through the Joint Steering Committee of WKD, is to operationalise how to collate key insights from research and analysis to effectively feed the policy making process at the local, national, and international levels, to inform or guide decision making (ie, increasing engagement of governments and organisations, like World Health Organization, United Nations, and regional organisations, especially in low-resource settings). There is a clear need for ongoing renewal of strategies to increase efforts at closing the gap in kidney health literacy, empowering those affected with kidney disease and their families, giving them a voice to be heard, and engaging with civil society. This year, the Joint Steering Committee of WKD declares “Kidney Health for All” as the theme of the 2022 WKD to emphasise and extend collaborative efforts among people with kidney disease, their care partners, healthcare providers, and all involved stakeholders for elevating education and awareness on kidney health and saving lives with this disease.
     
    Conclusions
    In bridging the gap of knowledge to improve outcomes for those with kidney disease on a global basis, an in-depth understanding of the needs of the community is required. The same can be said for policy development, understanding the processes in place for engagement of governments worldwide, all underpinned by the important principle of codesign of resources and policy that meets the needs of the community for which it is intended.
     
    For WKD 2022, kidney organisations, including the International Society of Nephrology and International Federation of Kidney Foundations—World Kidney Alliance, have a responsibility to immediately work towards shifting the patient-deficit health literacy narrative to that of being the responsibility of clinicians and health policy makers. Low health literacy occurs in all countries regardless of income status; hence, simple, low-cost strategies are likely to be effective. Communication, universal precautions, and teach-back can be implemented by all members of the kidney healthcare team. Through this vision, kidney organisations will lead the shift to improved patient-centred care, support for care partners, health outcomes, and the global societal burden of kidney healthcare.
     
    Author contributions
    All authors contributed equally to the conception, preparation, and editing of the manuscript.
     
    Conflicts of interest
    K Kalantar-Zadeh reports honoraria from Abbott, Abbvie, ACI Clinical, Akebia, Alexion, Amgen, Ardelyx, AstraZeneca, Aveo, BBraun, Cara Therapeutics, Chugai, Cytokinetics, Daiichi, DaVita, Fresenius, Genentech, Haymarket Media, Hospira, Kabi, Keryx, Kissei, Novartis, Pfizer, Regulus, Relypsa, Resverlogix, Dr Schaer, Sandoz, Sanofi, Shire, Vifor, UpToDate, and ZS-Pharma. V Liakopoulos reports nonfinancial support from Genesis Pharma. G Saadi reports personal fees from Multicare, Novartis, Sandoz, and AstraZeneca. E Tantisattamo reports nonfinancial support from Natera. Other authors declared no competing interests.
     
    Funding/support
    This editorial received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
     
    Declaration
    This article was published in Kidney International (Langham RG, Kalantar-Zadeh K, Bonner A, et al. Kidney health for all: bridging the gap in kidney health education and literacy. Kidney International. 2022;101(3):432-440. https://doi. org/10.1016/j.kint.2021.12.017), and reprinted concurrently in several journals. The articles cover identical concepts and wording, but vary in minor stylistic and spelling changes, detail, and length of manuscript in keeping with each journal’s style. Any of these versions may be used in citing this article.
     
    References
    1. Centers for Disease Control and Prevention. Healthy people 2030: What is health literacy? Available from: https://www.cdc.gov/healthliteracy/learn/index.html. Accessed 16 Jan 2022.
    2. Nutbeam D. The evolving concept of health literacy. Soc Sci Med 2008;67:2072-8. Crossref
    3. Lloyd A, Bonner A, Dawson-Rose C. The health information practices of people living with chronic health conditions: implications for health literacy. J Librariansh Inf Sci 2014;46:207-16. Crossref
    4. Sørensen K, Van den Broucke S, Fullam J, et al. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health 2012;12:80. Crossref
    5. Nutbeam D, Lloyd JE. Understanding and responding to health literacy as a social determinant of health. Annu Rev Public Health 2021;42:159-73. Crossref
    6. Shah JM, Ramsbotham J, Seib C, Muir R, Bonner A. A scoping review of the role of health literacy in chronic kidney disease self-management. J Ren Care 2021;47:221-33. Crossref
    7. Dinh HT, Nguyen NT, Bonner A. Healthcare systems and professionals are key to improving health literacy in chronic kidney disease. J Ren Care 2022;48:4-13. Crossref
    8. Dodson S, Good S, Osborne R. Health Literacy Toolkit for Low- and Middle-income Countries: a Series of Information Sheets to Empower Communities and Strengthen Health Systems. New Delhi: World Health Organization; 2015.
    9. Taylor DM, Fraser S, Dudley C, et al. Health literacy and patient outcomes in chronic kidney disease: a systematic review. Nephrol Dial Transplant 2018;33:1545-58. Crossref
    10. Taylor DM, Bradley JA, Bradley C, et al. Limited health literacy is associated with reduced access to kidney transplantation. Kidney Int 2019;95:1244-52. Crossref
    11. Brega AG, Barnard J, Mabachi NM, et al. AHRQ Health Literacy Universal Precautions Toolkit, Second Edition. (Prepared by Colorado Health Outcomes Program, University of Colorado Anschutz Medical Campus under Contract No. HHSA290200710008, TO#10.) AHRQ Publication No. 15-0023-EF. Rockville, MD: Agency for Healthcare Research and Quality; Jan 2015.
    12. Australian Commission on Safety and Quality in Health Care. Health literacy: taking action to improve safety and quality. Sydney: ACSQHC, 2014. Available from: https://www.safetyandquality.gov.au/publications-and-resources/resource-library/health-literacy-taking-action-improve-safety-and-quality. Accessed 17 Jan 2022.
    13. Visscher BB, Steunenberg B, Heijmans M, et al. Evidence on the effectiveness of health literacy interventions in the EU: a systematic review. BMC Public Health 2018;18:1414. Crossref
    14. Boonstra MD, Reijneveld SA, Foitzik EM, Westerhuis R, Navis G, de Winter AF. How to tackle health literacy problems in chronic kidney disease patients? A systematic review to identify promising intervention targets and strategies. Nephrol Dial Transplant 2020;36:1207-21. Crossref
    15. Nguyen NT, Douglas C, Bonner A. Effectiveness of selfmanagement programme in people with chronic kidney disease: a pragmatic randomized controlled trial. J Adv Nurs 2019;75:652-64. Crossref
    16. Synnot A, Bragge P, Lowe D, et al. Research priorities in health communication and participation: international survey of consumers and other stakeholders. BMJ Open 2018;8:e019481. Crossref
    17. Kalantar-Zadeh K, Li PK, Tantisattamo E, et al. Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere. Kidney Int 2021;99:278-84. Crossref
    18. Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 2019;96:1048-50. Crossref
    19. Li PK, Garcia-Garcia G, Lui SF, et al. Kidney health for everyone everywhere—from prevention to detection and equitable access to care. Kidney Int 2020;97:226-32. Crossref
    20. Gilford S. Patients helping patients: the Renal Support Network. Nephrol Nurs J 2007;34:76.
    21. Muhammad S, Allan M, Ali F, Bonacina M, Adams M. The renal patient support group: supporting patients with chronic kidney disease through social media. J Ren Care 2014;40:216-8. Crossref
    22. Li WY, Chiu FC, Zeng JK, et al. Mobile health app with social media to support self-management for patients with chronic kidney disease: prospective randomized controlled study. J Med Internet Res 2020;22:e19452. Crossref
    23. Pase C, Mathias AD, Garcia CD, Garcia Rodrigues C. Using social media for the promotion of education and consultation in adolescents who have undergone kidney transplant: protocol for a randomized control trial. JMIR Res Protoc 2018;7:e3. Crossref
    24. Kalantar-Zadeh K, Jafar T, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet 2021;398:786-802. Crossref
    25. Chen L, Sivaparthipan CB, Rajendiran S. Unprofessional problems and potential healthcare risks in individuals’ social media use. Work 2021;68:945-53. Crossref
    26. Henderson ML, Herbst L, Love AD. Social media and kidney transplant donation in the United States: clinical and ethical considerations when seeking a living donor. Am J Kidney Dis 2020;76:583-5. Crossref
    27. Henderson ML. Social media in the identification of living kidney donors: platforms, tools, and strategies. Curr Transplant Rep 2018;5:19-26. Crossref
    28. Newton K, van Deth JW, editors. Foundations of Comparative Politics Democracies of the Modern World. 2nd ed. Cambridge, UK: Cambridge University Press; 2010. Crossref
    29. Anderson JE. Public Policymaking: An Introduction. 2nd ed. Boston, MA: Houghton Mifflin; 1994.
    30. Young E, Quinn L, eds. Writing effective public policy papers: a guide to policy advisers in Central and Eastern Europe. Budapest, Hungary: Open Society Institute. 2002. Available from: https://www.icpolicyadvocacy.org/sites/icpa/files/downloads/writing_effective_public_policy_papers_young_quinn.pdf. Accessed 13 Dec 2021.
    31. Young E, Quinn L, eds. Making research evidence matter: a guide to policy advocacy in transition countries. Budapest, Hungary: Open Society Foundations. 2012. Available from: https://advocacyguide.icpolicyadvocacy.org/sites/icpa-book.local/files/Policy_Advocacy_Guidebook_2012.pdf. Accessed 13 Dec 2021.
    32. Start D, Hovland I. Tools for policy impact: a handbook for researchers, research and policy in development programme. London, UK: Overseas Development Institute. 2004. Available from: https://www.ndi.org/sites/default/files/Tools-for-Policy-Impact-ENG.pdf. Accessed 13 Dec 2021.

    Leveraging the power of health communication: messaging matters not only in clinical practice but also in public health

    Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
     
    EDITORIAL
    Leveraging the power of health communication: messaging matters not only in clinical practice but also in public health
    Harry HX Wang, PhD1,2,3 #; YT Li, MPH4 #; Martin CS Wong, MD, MPH5,6
    1 School of Public Health, Sun Yat-Sen University, Guangzhou, China
    2 Department of General Practice, The Second Hospital of Hebei Medical University, Shijiazhuang, China
    3 Usher Institute, Deanery of Molecular, Genetic and Population Health Sciences, The University of Edinburgh, Scotland, United Kingdom
    4 State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China
    5 JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
    6 Editor-in-Chief, Hong Kong Medical Journal
    # Equal contribution
     
    Corresponding author: Prof Martin CS Wong (wong_martin@cuhk.edu.hk)
     
     Full paper in PDF
     
    In routine clinical practice, communicating with patients in a clear and persuasive manner during patient-provider encounters is increasingly important for effective healthcare. This greatly helps in improving access to care and diagnostic safety, fostering continuous healing relationships, reducing medical errors, strengthening family and social support, enhancing care adherence, increasing patient satisfaction, and avoiding malpractice claims.1 2 3 Moreover, effective communication is a pivotal ingredient in patient engagement and shared decision-making across the care continuum from screening and diagnosis through palliative care built on the patient’s greater knowledge of health problems and the clinician’s better ability to recognise individual patient beliefs, values, needs, and preferences.4 This, in turn, enables the development and dissemination of evidence-based, personalised messages from clinicians to inform diagnosis, treatment options, prognosis, and the likelihood of severe adverse effects for achieving optimal care for patients.5
     
    The benefits of effective health communications in improving patient health outcomes and well-being also extend beyond clinical care. Whether to inform people about their health facts or to exert a long-lasting influence on their behaviour for living a healthier life, the use of different strategies is crucial in public health campaigns spanning a variety of areas, including the ongoing coronavirus disease 2019 (COVID-19) pandemic.6 7 Of equal importance is the integration of health communication in public advocacy and outbreak responses, which necessitate appropriate, practical, and straightforward messages that fill knowledge gaps for the target audience.
     
    From a public health perspective, eye health is a global imperative for achieving universal health coverage and many of the Sustainable Development Goals. Improving eye health contributes substantially to maintaining independence and daily life activities, improving quality of life and well-being, ensuring educational attainment and workplace productivity, and reducing poverty and inequalities.8 Similar to the prevention and management of most chronic diseases, promoting and improving eye health also require a life course approach that aims to minimise risk factors through evidence-based interventions at important life stages from as early as the perinatal period through early childhood to adolescence, and into older age. Therefore, school-based public health efforts that incorporate expertise of education and communication of health messages to facilitate long-term behaviour changes in children and adolescents would have the most impact on reducing disease risk factors and disease onset in later-life.9 Engagement in collaborative endeavours from both teachers and parents has been proven effective in the problem-solving process to support school-age children with developmental disorders and impairments in social interaction.10 Whether the school-family partnership underpinned by teacher-parent communication could be linked with improved behaviour changes, eg, vision screening attendance, in other specific disease contexts such as vision impairment warrants further investigation.
     
    Uncorrected refractive error, including myopia, hyperopia, astigmatism, and anisometropia, serve as the major and most easily avoidable cause of vision impairment among school-age children who are at risk of poor educational performance and social malfunctioning. In this issue of the Hong Kong Medical Journal, Du et al11 explore the association between teacher-parent communication and eye-health seeking behaviours of primary school students in a cross-sectional study conducted in rural China. The authors found that the delivery of a single clear message to parents from the teacher on the student’s inability to see the blackboard clearly could substantially improve the refractive examination attendance and spectacles wearing among students. It adds evidence to extend the benefits of teacher-parent communication beyond better educational experiences, coordinated learning environments, improved academic achievements, and enhanced habits development in daily life. The findings also provide impetus for further in-depth research to advance our understanding of the extent to which different modalities of teacher-parent interactions could inform, educate and empower parents about their child’s eye health issues. This may help in generating evidence for developing well-integrated, innovative strategies to plan and implement school-based eye health initiatives featured by strengthened partnership with teachers, parents, students, and the wider community to address undiagnosed or untreated refractive error and other vision impairment.
     
    At the global level, an earlier report from the World Health Organization in 2019 highlighted the considerable challenges of a continuum of eye care throughout people’s lives: over 2 billion people worldwide are visually impaired or blind, and nearly half of vision impairments could have been prevented or have yet to be addressed through cost-effective and feasible health interventions.12 The subsequent 74th World Health Assembly organised in April 2021 has endorsed the global targets for effective coverage of refractive errors and cataract surgery—the two leading causes of vision impairment and blindness. A 40% point increase in effective coverage of refractive error and a 30% point increase in effective coverage of cataract surgery is envisaged by 2030. Apart from refractive errors and cataract, there are a range of other common ophthalmic conditions that pose enormous threats to healthcare such as glaucoma and diabetic retinopathy, which can lead to eye vision loss if not detected and treated early. Most recently, the Resolution entitled ‘Vision for Everyone; accelerating action to achieve the Sustainable Development Goals’ has been adopted by the United Nations General Assembly in July 2021 to urge the implementation of integrated people-centred eye care in health systems across the wide spectrum of promotive, preventive, curative and rehabilitative services by 2030. The United Nations vision underscores the significance of raising awareness and engaging and empowering people and communities pertaining to eye care needs and the importance of vision for all. To achieve this goal, eye health education and promotion within the wider community needs to reduce barriers that impede the affective dimensions of message dissemination and to optimise knowledge communication and service uptake.
     
    However, achieving effective communication of health messages is never an easy task. Previous studies highlighted the increasing need for strengthening health communication and promotion in socially disadvantaged groups,13 or those living in deprived areas,14 and for care empowerment in managing underdiagnosed long-term conditions that require better professional education and tailored messages in primary care.15 16 The need for health communication efforts and mass media messages promoting infection control measures and use of guidelines in public education is also highlighted in risk communications and community engagement against the COVID-19 outbreak.17
     
    A growing body of evidence indicates that digital communication, eg, mobile messaging for telecommunications or social media platform characterised by multi-channel communications, may offer innovative means for sharing, disseminating and amplifying health messages across all aspects of the communication spectrum to target audience and communities with unique merits such as enhanced audio-visual capabilities, improved attendance at healthcare appointments, and increased uptake of comprehensive eye examinations.18 19
     
    The World Health Organization has also proposed a strategic framework that highlights the principles of accessible, relevant, actionable, timely, credible and trusted, and understandable communication.20 The framework could be used a basis for operationalising effective, integrated and coordinated communication across a broad range of health issues from chronic conditions (eg, vision impairment) to emerging risks (eg, COVID-19), and for measuring the impact of tailored communication efforts on health and well-being over time. A further step towards empirical evidence from well-designed studies on the impact of enhanced health communication with individuals and their families on disease prevention, health promotion, and quality of life through public health measures and its enablers would pave the way for achieving universal health coverage for individuals, communities, and society at large.
     
    Author contributions
    All authors contributed to the concept or design; acquisition of data; analysis or interpretation of data; drafting of the article; and critical revision for important intellectual content. All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
     
    Conflicts of interest
    The authors have declared no conflict of interest.
     
    References
    1. Street RL Jr, Makoul G, Arora NK, Epstein RM. How does communication heal? Pathways linking clinician-patient communication to health outcomes. Patient Educ Couns 2009;74:295-301. Crossref
    2. van Dael J, Gillespie A, Neves AL, Darzi A. Patient–clinician communication research for 21st century health care. Br J Gen Pract 2022;72:52-3. Crossref
    3. Burgener AM. Enhancing communication to improve patient safety and to increase patient satisfaction. Health Care Manag (Frederick) 2020;39:128-32. Crossref
    4. Kaldjian LC. Concepts of health, ethics, and communication in shared decision making. Commun Med 2017;14:83-95. Crossref
    5. Vermeir P, Vandijck D, Degroote S, et al. Communication in healthcare: a narrative review of the literature and practical recommendations. Int J Clin Pract 2015;69:1257-67. Crossref
    6. Edwards DJ. Ensuring effective public health communication: insights and modeling efforts from theories of behavioral economics, heuristics, and behavioral analysis for decision making under risk. Front Psychol 2021;12:715159. Crossref
    7. Nan X, Iles IA, Yang B, Ma Z. Public health messaging during the COVID-19 pandemic and beyond: lessons from communication science. Health Commun 2022;37:1-19. Crossref
    8. Burton MJ, Ramke J, Marques AP, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health 2021;9:e489-551. Crossref
    9. Bay JL, Hipkins R, Siddiqi K, et al. School-based primary NCD risk reduction: education and public health perspectives. Health Promot Int 2017;32:369-79. Crossref
    10. Azad GF, Kim M, Marcus SC, Mandell DS, Sheridan SM. Parent-teacher communication about children with autism spectrum disorder: an examination of collaborative problem-solving. Psychol Sch 2016;53:1071-84. Crossref
    11. Du K, Huang J, Guan H, Zhao J, Zhang Y, Shi Y. Teacher-to-parent communication and vision care-seeking behaviour among primary school students. Hong Kong Med J 2022;28:152-60. Crossref
    12. World Health Organization. World Report on Vision. Geneva: World Health Organization; 2019.
    13. Hon KL, Leung KK. Healthcare and health promotion for the sub-health state Hong Kong population. Hong Kong Med J 2021;27:73. Crossref
    14. Zhou Q, An Q, Wang N, et al. Communication skills of providers at primary healthcare facilities in rural China. Hong Kong Med J 2020;26:208-15. Crossref
    15. Lam K, Chan WS, Luk JK, Leung AY. Assessment and diagnosis of dementia: a review for primary healthcare professionals. Hong Kong Med J 2019;25:473-82. Crossref
    16. Kalantar-Zadeh K, Li PK, Tantisattamo E, et al. Living well with kidney disease by patient and care partner empowerment: kidney health for everyone everywhere. Hong Kong Med J 2021;27:97-8. Crossref
    17. Yu EY, Leung WL, Wong SY, Liu KS, Wan EY; HKCFP Executive and Research Committee. How are family doctors serving the Hong Kong community during the COVID-19 outbreak? A survey of HKCFP members. Hong Kong Med J 2020;26:176-83. Crossref
    18. Atta S, Omar M, Kaleem SZ, Waxman EL. The use of mobile messaging for telecommunications with patients in ophthalmology: a systematic review. Telemed J E Health 2022;28:125-37. Crossref
    19. Maitra C, Rowley J. Delivering eye health education to deprived communities in India through a social media-based innovation. Health Info Libr J 2021;38:139-42. Crossref
    20. World Health Organization. Strategic Communications Framework for WHO in the Western Pacific Region. Manila: WHO Regional Office for the Western Pacific; 2017.

    Breast cancer screening—towards a broader coverage of the general population

    Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
     
    EDITORIAL
    Breast cancer screening—towards a broader coverage of the general population
    CY Lui, FHKCR, FHKAM (Radiology)1; Julian CY Fong, FHKCR, FHKAM (Radiology)1; Martin CS Wong, MD, MPH2,3
    1 Hong Kong Women’s Imaging Limited, Hong Kong
    2 Jockey Club School of Public Health and Primary Care, The Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
    3 Editor-in-Chief, Hong Kong Medical Journal
     
    Corresponding author: Dr CY Lui (cylui@hkwi.com.hk)
     
     Full paper in PDF
     
    The primary purpose of breast cancer screening is to detect breast cancer earlier at an asymptomatic stage hopefully before it becomes more advanced or metastasised, which is the major cause of patient death. The breast cancer detected under screening are usually smaller in size with better prognosis,1 2 and patients can therefore benefit from less extensive surgical treatment with fewer complications such as lymphoedema. It may also reduce morbidity secondary to the use of systematic chemotherapy, and lower its recurrence rate
     
    In 2021, the Cancer Expert Working Group on Cancer Prevention and Screening (CEWG) updated its recommendations on breast cancer screening for the female general population of Hong Kong. Women with certain combinations of risk factors are recommended to consider mammography screening every 2 years.3 Addressing the rising breast cancer incidence in Hong Kong, the updated recommendation is a big leap forward compared to the previous version which only mentioned ‘insufficient scientific evidence to recommend or against mammography screening’.
     
    The benefits of mammography have been widely reported in Western populations.4 However, whether studies from Western populations are directly applicable in Chinese populations remains controversial, primarily because this population generally has denser breast tissue and difference in incidence. In this respect, a 10-year study conducted in Taiwan, involving over 1.4 million women of mainly Chinese ethnicity, found that universal biennial mammography was associated with reduction of mortality by 41% and stage II+ breast cancer by 30%, compared with annual clinical breast examination.5 In Hong Kong, Lui et al6 found that the crude cancer detection rate of an opportunistic screening programme was five per 1000 mammograms performed. Experience from Hong Kong Breast Cancer Foundation found a detection rate of 7.5 per 1000 asymptomatic women screened.7 These data suggested that mammography screening is useful to detect breast cancers in Hong Kong.
     
    Potential risks of breast screening have also been overstated, including overdiagnosis and overtreatment of ductal carcinoma in situ (DCIS) detected by mammography screening. However, Duffy et al8 studied over 5 million women screened in the United Kingdom for four consecutive yearly screening rounds, and showed that there was a significant negative association between detection of DCIS at screening and invasive interval cancers. For every three screen-detected DCIS, there was one less invasive interval cancer over the next 3 years. These results indicate that early detection of DCIS and subsequent treatment is worthwhile in prevention of future invasive diseases.
     
    Another risk that is often overstated is the effect of screening causing anxiety among patients. Anxiety in patients who received breast cancer screening tends to be short-term, and these women have a high tolerance for false positive results.9 10 11 Findings from the longitudinal DMIST (Digital Mammographic Imaging Screening Trial) showed that the anxiety associated with false positive mammogram was only transient with no measurable health utility decrement, yet it increased women’s intention to undergo future breast cancer screening.12 Although there is potential for false positive results to cause anxiety and lead to unnecessary biopsy and treatment, the situation can be much alleviated with updated technology and quality assurance by experts with adequate experience in breast screening.
     
    Bilateral two-view full-field digital mammography is currently the standard of screening mammography. With technological advancements, digital breast tomosynthesis (DBT), also known as 3D mammogram, has become more widely used. Friedewald et al13 found that DBT was associated with a 41% increase in invasive cancer detection, 49% increase in positive predictive value for recall, 21% increase in positive predictive value for biopsy, and 15% reduction of overall number of recalls.
     
    Older studies reported that the radiation dose of DBT was much higher than that of conventional two-dimensional (2D) digital mammography. However, these studies often compared the radiation dose between “DBT combined with digital mammography” and “digital mammography only”. Using newer DBT technology with synthesised 2D mammogram capacity without separate scanning for 2D images, the radiation dose of DBT is comparable to that of conventional 2D digital mammography—and just less than half of the United States Food and Drug Administration Mammography Quality Standards Act dose limit for mammography.14 And with the use of DBT, it is associated with fewer additional radiation exposure from recall for additional cone compression view. This newer DBT technology is now widely available in Hong Kong.
     
    To implement a successful breast cancer screening programme in Hong Kong, modern hardware and manpower readiness are equally important. The imaging centre should have mammography machines, radiographers, and radiologists that meet the standards recommended by Hong Kong College of Radiologists.15 Quality assurance, including regular auditing of the programme’s performance should be in place. Multidisciplinary meetings with radiologists, surgeons, pathologists, and oncologists working in as a team should be held regularly to discuss relevant cases and to facilitate further investigations or treatment plans. There should also be administrative support to follow up on screening and biopsy results, and provide timely arrangement of further investigation or treatment if cancer is suspected or confirmed. A system should be implemented to remind patients to attend the next screening appointment.
     
    To prepare for large-scale breast cancer screening, forward planning is essential, such as training of an adequate number of mammographers, radiologists with a special interest in breast screening, and breast surgeons specialised in early breast cancer surgery and treatment.
     
    Whereas the risks of screening are frequently discussed, the harms of not screening are often overlooked. Those women not attending screening are associated with development of a significantly larger tumour, a more advanced stage of disease at diagnosis, poorer prognosis, lower survival rate, and higher recurrence rate. There is also a higher cost and extent of treatment, especially if there is a need for chemotherapy for advanced disease. It has been estimated that the cost of treating advanced metastatic breast cancer exceeds US$250 000 per patient, and the average cost of treating advanced cancer in the first year after diagnosis is almost double that of early cancers.16 In addition to the cost for treatment, there are extra societal costs, including productivity loss and staff turnover, as well as the time and expenses of the caretakers of the patients.
     
    The relatively dense breast tissue among Chinese women not only impairs the performance and resulting benefits of mammography, but also is an independent risk factor for breast cancer. The technology of DBT, supplemented by ultrasound or magnetic resonance imaging (MRI), may be used to enhance the sensitivity for detecting cancer. Whereas supplementary ultrasound is widely used because of its easy availability, a recent study found that contrast enhanced MRI provides the greatest increase in cancer detection and reduce interval cancers and late-stage disease.17 The abbreviated MRI technique will reduce the cost and improve the availability of this technology. It is hoped that the CEWG may take this newer evidence into consideration in its next update.
     
    With the updated recommendation of CEWG on risk-based screening, and the experience of opportunistic mammography screening in Hong Kong since 1993,6 we believe that Hong Kong should have the capability and expertise to organise quality, population-based screening similar to other Asian countries and cities. Because breast screening is a primary care activity, we anticipate that district health centres may play a crucial role to enhance awareness and promote its implementation in the community as one of their key roles and functions. We are confident that the findings from evaluation of the Breast Cancer Screening Pilot Programme started on 6 September 2021 could further inform policy formulation.
     
    Author contributions
    All authors contributed to the editorial, approved the final version for publication, and take responsibility for its accuracy and integrity.
     
    Conflicts of interest
    The authors have declared no conflict of interest.
     
    References
    1. Tabar L, Tot T, Dean PB. Breast Cancer—The Art and Science of Early Detection with Mammography: Perception, Interpretation, Histopathologic Correlation. Germany: Thieme; 2004: 174-7.
    2. Tabár L, Duffy SW, Vitak B, Chen HH, Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999;86:449-62. Crossref
    3. Cancer Expert Working Group on Cancer Prevention and Screening (August 2018 to July 2021); Tsang TH, Wong KH, Allen K, et al. Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening. Hong Kong Med J 2022;28:161-8.
    4. Sitt JC, Lui CY, Sinn LH, Fong JC. Understanding breast cancer screening—past, present, and future. Hong Kong Med J 2018;24:166-74. Crossref
    5. Yen AM, Tsau HS, Fann JC, et al. Population-based breast cancer screening with risk-based and universal mammography screening compared with clinical breast examination: a propensity score analysis of 1 429 890 Taiwanese women. JAMA Oncol 2016;2:915-21. Crossref
    6. Lui CY, Lam HS, Chan LK, et al. Opportunistic breast cancer screening in Hong Kong; a revisit of the Kwong Wah Hospital experience. Hong Kong Med J 2007;13:106-13.
    7. Hong Kong Breast Cancer Foundation. Fact Sheet (last updated on 1 April 2021). Available from: https://www.hkbcf.org/en/about_us/main/upload/category/442/self/6080f662635ff.pdf. Accessed 20 Mar 2022.
    8. Duffy SW, Dibden A, Michalopoulos D, et al. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study. Lancet Oncol 2016;17:109-14. Crossref
    9. Lowe JB, Balanda KP, Del Mar C, Hawes E. Psychologic distress in women with abnormal findings in mass mammography screening. Cancer 1999;85:1114-8. Crossref
    10. Ekeberg Ø, Skjauff H, Kåresen R. Screening for breast cancer is associated with a low degree of psychological distress. Breast 2001;10:20-4. Crossref
    11. Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women’s attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ 2000;320:1635-40. Crossref
    12. Tosteson AN, Fryback DG, Hammond CS, et al. Consequences of false-positive screening mammograms. JAMA Intern Med 2014;174:954-61. Crossref
    13. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 2014;311:2499-507. Crossref
    14. Skaane P, Bandos AI, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology 2014;271:655-63. Crossref
    15. Mammography Statement. Revised version 2015. Hong Kong College of Radiologists. Available from: https://www.hkcr.org/templates/OS03C00336/case/lop/HKCR%20Mammography%20Statement_rev20150825.pdf. Accessed 20 Mar 2022.
    16. Montero AJ, Eapen S, Gorin B, Adler P. The economic burden of metastatic breast cancer: a U.S. managed care perspective. Breast Cancer Res Treat 2012;134:815-22. Crossref
    17. Berg WA, Rafferty EA, Friedewald SM, Hruska CB, Rahbar H. Screening algorithms in dense breasts: AJR Expert Panel Narrative Review. AJR Am J Roentgenol 2021;216:275-94. Crossref

    Pages